Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16006,37,1.69 [0.25-11.46],0.591849198185942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15538,37,0.66 [0.35-1.23],0.190523341066147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18321,48,1.55 [1.00-2.41],0.0518832390482811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15460,36,1.43 [0.62-3.31],0.4025377225403493
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18204,48,1.10 [0.70-1.73],0.6912494144545419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18321,48,1.01 [0.69-1.48],0.9490727717948916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16003,38,1.00 [0.81-1.24],0.9676314345262176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15460,36,0.82 [0.50-1.36],0.4465298806092063
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",17994,48,0.81 [0.58-1.13],0.2092646641955634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15707,38,1.33 [0.97-1.81],0.0763947618005653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",15983,38,0.85 [0.59-1.23],0.3885002474612841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18215,49,1.71 [0.67-4.38],0.2660247767823929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16003,38,1.18 [0.39-3.60],0.7739943040870825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18087,48,0.74 [0.44-1.25],0.2624406271709091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15631,36,0.59 [0.22-1.58],0.2967226484680961
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,15929,37,0.92 [0.70-1.22],0.5783057966209451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18412,50,0.89 [0.53-1.50],0.6704402194728769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15505,38,1.25 [0.67-2.34],0.4912312053897335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18489,50,1.28 [0.60-2.72],0.5269940563096387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18561,48,0.89 [0.63-1.26],0.5081760433860776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,15926,38,0.52 [0.21-1.24],0.1405076052384499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15505,38,1.04 [0.78-1.39],0.7851324769589691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15460,36,0.88 [0.33-2.35],0.8003819653412405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18087,48,0.90 [0.48-1.67],0.7286065973147487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15460,36,1.18 [0.74-1.88],0.4934149480310051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18105,49,1.53 [0.89-2.61],0.1222706741316951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18227,48,1.97 [0.78-4.96],0.1507705446032913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18412,50,0.76 [0.50-1.16],0.2014590366672958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15460,36,0.98 [0.54-1.77],0.9375023469374564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15583,36,0.92 [0.56-1.52],0.748928343503066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18631,49,0.73 [0.34-1.54],0.4052335880117471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18330,49,1.12 [0.63-2.00],0.7056740525585778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15505,38,1.32 [0.55-3.16],0.5267755117259939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18087,48,0.53 [0.23-1.22],0.1359822810520143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18261,48,1.68 [0.83-3.42],0.151649709027858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18631,49,1.12 [0.54-2.33],0.7601893409633363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18545,49,0.99 [0.41-2.39],0.979365274019181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,15929,37,1.01 [0.36-2.87],0.9781893939427864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15505,38,1.21 [0.47-3.11],0.6895729964515731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18641,50,1.79 [0.60-5.31],0.2935187153811202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18321,48,0.81 [0.44-1.49],0.4917443502346891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18087,48,0.50 [0.19-1.36],0.1746637400874339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15505,38,0.82 [0.33-2.01],0.6582129137706262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18453,48,0.79 [0.45-1.36],0.3919542091619915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,15991,37,0.51 [0.19-1.38],0.1855739431903683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15538,37,2.01 [0.62-6.46],0.241608895112136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,15983,38,0.83 [0.38-1.82],0.637996169650668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,17994,48,0.43 [0.15-1.25],0.1212904249722431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15631,36,0.93 [0.59-1.47],0.7670793736122962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18227,48,1.11 [0.52-2.38],0.7878917010998603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15631,36,0.65 [0.28-1.49],0.3073498746168924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,15929,37,0.69 [0.38-1.28],0.2394339940225017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18471,49,0.90 [0.37-2.19],0.8097908346101477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18550,49,1.09 [0.49-2.45],0.8325790535778524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,15983,38,0.55 [0.17-1.79],0.3240209872627709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18321,48,0.93 [0.68-1.28],0.6761684258533622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18412,50,1.27 [0.49-3.26],0.62142483697125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15499,37,1.08 [0.72-1.64],0.7014708130255112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15631,36,1.08 [0.71-1.64],0.70944123989067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18087,48,0.87 [0.63-1.21],0.4122766271241679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16006,37,0.95 [0.60-1.50],0.8245997334047164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18584,48,1.02 [0.37-2.77],0.9758580603468004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15460,36,0.76 [0.43-1.36],0.3582869535034958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15631,36,1.13 [0.78-1.64],0.5108707858926378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16006,37,1.32 [0.28-6.22],0.7241326568487848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18194,48,1.22 [0.83-1.81],0.314169780010612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15499,37,0.93 [0.67-1.29],0.6601901587965134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18350,48,0.95 [0.51-1.80],0.8808123495825267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,17886,48,1.03 [0.79-1.34],0.8426914332579504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,17968,48,0.93 [0.60-1.46],0.7621829722772464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18471,49,0.83 [0.39-1.77],0.6254768802385594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18631,49,1.09 [0.66-1.80],0.7347449260939025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16003,38,1.59 [0.43-5.91],0.4877749003551893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18412,50,0.89 [0.63-1.25],0.495855154763394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18412,50,0.89 [0.61-1.31],0.5584349405792881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15538,37,0.56 [0.19-1.64],0.293725671271315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15538,37,0.57 [0.18-1.80],0.3373199968890235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,15926,38,0.90 [0.54-1.50],0.6890858915504194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16003,38,1.68 [0.55-5.15],0.3641629499361036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18373,49,1.39 [1.02-1.91],0.0386362538216963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15575,36,0.96 [0.65-1.41],0.8202248318995118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,17994,48,1.10 [0.68-1.79],0.6960599277849997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15538,37,0.81 [0.41-1.60],0.5421185670790685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18298,48,0.90 [0.71-1.16],0.429024051578261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18412,50,1.17 [0.79-1.72],0.4272668452089583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",15954,38,0.94 [0.70-1.26],0.682154325081731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15631,36,0.47 [0.09-2.54],0.3823573604359261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,17994,48,1.17 [0.83-1.64],0.3682550859143049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15575,36,0.81 [0.47-1.42],0.4670410964332335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18087,48,1.20 [0.77-1.88],0.4180017232144528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15505,38,1.11 [0.72-1.73],0.6321906176352874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18017,48,1.13 [0.76-1.67],0.5480225582627358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,15961,38,1.05 [0.82-1.34],0.7009905156683485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,17908,48,0.85 [0.54-1.34],0.4864446077598779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18641,50,1.36 [0.38-4.85],0.6377584427747658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18411,49,1.24 [0.79-1.94],0.3446817891558829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",15926,38,1.13 [0.66-1.95],0.6509601186495902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18374,49,0.92 [0.62-1.35],0.6577929763620232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",15961,38,1.08 [0.57-2.06],0.8124404719318773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15707,38,1.14 [0.59-2.21],0.7002074531256864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15505,38,1.08 [0.85-1.39],0.5259944128301373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18321,48,0.94 [0.74-1.20],0.6193284230443277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18105,49,1.71 [0.92-3.20],0.0913996509122613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18558,48,2.52 [0.73-8.75],0.1445329073648781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,15991,37,1.20 [0.35-4.08],0.7694031392105218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18017,48,1.14 [0.78-1.65],0.4942011053378031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15575,36,1.25 [0.75-2.10],0.3902317032606641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18321,48,1.01 [0.34-2.99],0.9846223978813504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18105,49,0.98 [0.57-1.69],0.9459308083016278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15631,36,1.72 [0.79-3.75],0.1697686501249181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,15860,38,0.91 [0.47-1.79],0.7952299969907891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,15954,38,1.19 [0.77-1.85],0.4293469773016222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,14984,35,1.00 [0.53-1.92],0.9907550295856112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17742,48,1.07 [0.63-1.81],0.7967553298812189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17188,47,1.08 [0.64-1.82],0.7798227121949035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18387,49,1.61 [0.80-3.25],0.1800753381581014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18334,48,0.76 [0.57-1.03],0.0741550590771805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18584,48,0.66 [0.32-1.35],0.2520105814758506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18134,50,0.56 [0.23-1.35],0.1935600439875909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18403,49,0.80 [0.42-1.53],0.4988990917978096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18446,49,1.39 [0.66-2.92],0.3914689548748494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18450,49,1.11 [0.62-1.96],0.7297461526968134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18584,48,0.79 [0.39-1.59],0.5037832980992816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15460,36,1.17 [0.78-1.76],0.4444844739996927
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15505,38,0.98 [0.67-1.45],0.9345165117047016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15431,38,0.68 [0.37-1.27],0.2288937867612409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,17994,48,1.25 [0.85-1.84],0.252427903611957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15538,37,1.48 [0.87-2.51],0.1472083493855797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18475,49,1.33 [0.54-3.27],0.5347137979601067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15552,36,1.23 [0.66-2.32],0.5120891676291525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18017,48,0.71 [0.49-1.03],0.0702458336310911
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18368,49,1.24 [0.83-1.85],0.3033589018098853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15315,37,0.99 [0.62-1.57],0.9531965792389542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18545,49,1.21 [0.85-1.72],0.2858825443078008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18333,50,1.15 [0.82-1.62],0.4134206683347554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,17954,48,0.90 [0.38-2.16],0.8205336887084601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18105,49,1.36 [0.98-1.89],0.0690811441792562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18500,49,0.79 [0.33-1.85],0.5844737259746361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,15926,38,0.85 [0.57-1.28],0.4369933930659527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15575,36,1.03 [0.53-2.01],0.9196835504341404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,15929,37,1.06 [0.71-1.60],0.770232163603932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,15954,38,1.18 [0.63-2.21],0.6028633547910633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18321,48,1.12 [0.66-1.90],0.6819495428119784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,15862,37,1.92 [0.70-5.24],0.2026366235317311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18533,48,1.25 [0.83-1.88],0.2862749355702922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18412,50,1.67 [1.05-2.67],0.0308616524071243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16006,37,1.28 [0.42-3.90],0.6681105549870779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16003,38,0.78 [0.42-1.47],0.4426919165723365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16006,37,1.43 [0.61-3.34],0.408531438967411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16003,38,0.99 [0.26-3.78],0.9892560831134106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15538,37,1.39 [0.64-3.01],0.4071661268116611
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,15981,37,0.69 [0.29-1.66],0.4108777731461991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15293,33,0.49 [0.17-1.41],0.1879245394033568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16006,37,0.77 [0.42-1.41],0.4023720360174667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16003,38,0.98 [0.26-3.72],0.9798264602777438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18411,49,1.46 [0.76-2.78],0.2547955657014251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16003,38,1.19 [0.68-2.10],0.5350109656878006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18478,49,1.07 [0.44-2.60],0.873783691051195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18387,49,0.82 [0.56-1.22],0.3271083274949407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15631,36,0.90 [0.68-1.19],0.4583490529633127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18231,48,1.41 [0.80-2.49],0.2314033925923166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15707,38,1.00 [0.63-1.59],0.9878753764947472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18321,48,0.59 [0.29-1.23],0.1582108149339018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,15929,37,0.97 [0.73-1.30],0.8401941247666879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,15961,38,1.15 [0.74-1.80],0.5313626773462745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18307,46,1.18 [0.71-1.96],0.5227255301259393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",15926,38,0.81 [0.36-1.84],0.6154061300692864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,17994,48,1.22 [0.71-2.11],0.4731513220001908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,17994,48,0.70 [0.44-1.12],0.1406055596214251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15707,38,1.06 [0.52-2.18],0.8640307828626089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15631,36,0.93 [0.63-1.38],0.7196129509927416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15431,38,0.81 [0.51-1.30],0.3857062343016704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,15954,38,0.96 [0.68-1.36],0.8242717315846936
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,15961,38,1.07 [0.78-1.49],0.6666825000797272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18405,49,1.02 [0.80-1.30],0.8857443375840925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15499,37,0.75 [0.46-1.23],0.2591615847186302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15499,37,1.39 [0.71-2.75],0.3398164878066668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18017,48,0.99 [0.53-1.88],0.9853462418781856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15460,36,0.86 [0.52-1.40],0.5355288126595112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15460,36,1.09 [0.49-2.39],0.8367232710196527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15499,37,1.20 [0.77-1.87],0.425810889472101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18105,49,1.47 [0.87-2.47],0.1475807025281004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15460,36,0.46 [0.18-1.20],0.1128200442597195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18411,49,0.89 [0.50-1.60],0.6977746699214438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18321,48,0.73 [0.45-1.18],0.192501357416335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18500,49,1.22 [0.60-2.48],0.5735132897098838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15499,37,0.87 [0.48-1.57],0.6428233148749185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18105,49,1.15 [0.70-1.89],0.5908432241249626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,15850,37,1.00 [0.50-1.99],0.9952217948672528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18261,48,1.24 [0.74-2.07],0.421179231098157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18261,48,1.44 [0.63-3.27],0.384747048383831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16003,38,1.88 [0.61-5.81],0.2714250191209806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,15983,38,0.66 [0.21-2.15],0.4942184970160411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,15961,38,1.07 [0.67-1.71],0.7723486080911326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15538,37,0.97 [0.71-1.34],0.8690363670878638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15460,36,0.96 [0.63-1.47],0.8571796150312325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18017,48,1.02 [0.70-1.48],0.9154963088773262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15431,38,0.99 [0.39-2.54],0.981953652983675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,15929,37,0.99 [0.68-1.43],0.9554718437841376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,17994,48,1.31 [0.87-1.97],0.1950144446620091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18453,48,1.19 [0.83-1.71],0.3435367152444281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15460,36,1.13 [0.62-2.04],0.6953590760425521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15460,36,0.99 [0.37-2.69],0.989569096696037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15460,36,0.67 [0.25-1.79],0.4287529386170786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15431,38,0.88 [0.40-1.92],0.7433463461574121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15460,36,1.02 [0.62-1.67],0.9518233386336508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15460,36,1.31 [0.82-2.09],0.2651898197032873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18471,49,0.92 [0.73-1.16],0.4815011225177945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18017,48,0.78 [0.40-1.51],0.4586075146422075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,17994,48,1.38 [0.82-2.33],0.2254730367538175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18321,48,1.22 [0.51-2.91],0.6593924090837473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,17989,48,1.05 [0.72-1.54],0.8019604655802356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15538,37,1.19 [0.78-1.82],0.4198533475138678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15460,36,0.80 [0.56-1.13],0.2059667237475122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,15929,37,0.96 [0.32-2.85],0.9349059886583276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16006,37,4.94 [0.85-28.74],0.0754595257098607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18017,48,0.88 [0.62-1.26],0.4884060967913576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15499,37,0.90 [0.64-1.26],0.5260599748380644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,15961,38,0.72 [0.34-1.51],0.3855275546617909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,15954,38,1.33 [0.82-2.16],0.2435178202568402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18405,49,1.01 [0.78-1.32],0.9296051206065056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18500,49,0.85 [0.33-2.19],0.7439544284791575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,15961,38,1.03 [0.59-1.80],0.9075730304528984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,17874,49,1.45 [1.14-1.83],0.0023473624151155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16006,37,1.46 [0.85-2.49],0.1676559239064837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15460,36,0.93 [0.19-4.50],0.9233107115943922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15538,37,0.54 [0.24-1.23],0.1422476593783226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18471,49,1.10 [0.44-2.76],0.8452984820219626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18411,49,1.35 [0.48-3.80],0.5678306541840059
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15505,38,1.20 [0.45-3.23],0.7165642896896487
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18405,49,1.09 [0.78-1.53],0.6190965463261462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18227,48,1.17 [0.61-2.26],0.6400206058641877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15505,38,1.09 [0.59-2.01],0.78154379278689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18087,48,1.15 [0.57-2.32],0.6911971201924445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,17994,48,0.97 [0.65-1.45],0.8872688756016186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,17994,48,1.19 [0.50-2.84],0.7008550995566161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18405,49,1.02 [0.81-1.30],0.8476189001040677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,15954,38,1.08 [0.72-1.64],0.7073931849439006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15575,36,0.84 [0.52-1.33],0.4498486546357997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,17987,48,0.90 [0.67-1.19],0.4521341053375811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18411,49,0.52 [0.18-1.52],0.2313302119339414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18261,48,1.51 [0.72-3.16],0.2764627728320081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",15983,38,0.66 [0.22-1.96],0.4549669823826918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15499,37,0.68 [0.32-1.46],0.3267233569994155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15708,38,1.32 [0.40-4.38],0.6467981881013701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,15929,37,0.68 [0.33-1.38],0.2859414952998343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,15954,38,1.00 [0.73-1.37],0.984120859066479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18405,49,0.74 [0.42-1.30],0.2947657912705811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15505,38,1.42 [0.95-2.12],0.0849434251103636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15431,38,0.88 [0.52-1.49],0.6422893657414533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,15926,38,1.13 [0.62-2.05],0.6941051636746984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18405,49,1.02 [0.78-1.35],0.8770106693268568
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,15991,37,0.73 [0.51-1.04],0.0853879448568077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15538,37,1.07 [0.63-1.83],0.804461233041475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15431,38,0.97 [0.48-1.95],0.9288224477345604
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,15991,37,0.84 [0.57-1.24],0.3839463749490183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,17968,48,0.89 [0.71-1.12],0.3179161554160635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15499,37,0.97 [0.60-1.54],0.8841471028181624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15460,36,2.22 [0.78-6.33],0.1362712677681115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18405,49,1.05 [0.72-1.53],0.7937265478116899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18411,49,1.04 [0.79-1.38],0.7664992925171784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,17994,48,0.94 [0.62-1.42],0.762019121435755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18641,50,1.31 [0.58-2.93],0.5155711411753828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15505,38,0.72 [0.29-1.77],0.4685051016289405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15499,37,1.44 [1.11-1.86],0.0061382510524711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,15954,38,0.98 [0.45-2.11],0.9491365742086344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18411,49,1.26 [0.88-1.80],0.2138455653620853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15631,36,0.63 [0.21-1.86],0.4016569928374959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18227,48,0.98 [0.56-1.73],0.9553247732572778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18057,48,0.76 [0.40-1.46],0.4120661906852519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15631,36,0.70 [0.17-2.93],0.624167802961102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,15983,38,0.78 [0.30-2.01],0.606127545131266
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15505,38,1.29 [0.65-2.53],0.4643495115765449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18087,48,0.43 [0.14-1.30],0.1342784188474465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15499,37,1.12 [0.64-1.96],0.7009557661807748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15538,37,1.40 [0.77-2.54],0.2743360591254812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,14997,36,1.13 [0.84-1.52],0.4062262819554312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18383,48,1.23 [0.83-1.81],0.3027654562368479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,15955,38,1.03 [0.63-1.70],0.8992028651299327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15767,37,1.03 [0.77-1.38],0.8329458412648418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15707,38,1.31 [0.51-3.37],0.5744980181262751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15499,37,1.48 [0.74-2.95],0.2693454118335314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15460,36,1.15 [0.66-2.01],0.6152096087285828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15460,36,0.54 [0.22-1.33],0.1801709371883861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18017,48,1.03 [0.58-1.83],0.9199781573450838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15499,37,1.20 [0.61-2.36],0.592301255624496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,15961,38,0.67 [0.27-1.71],0.4077301886424312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18598,49,1.18 [0.34-4.17],0.7942820687119744
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15431,38,0.76 [0.27-2.14],0.6091427935858529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18575,49,1.57 [0.78-3.18],0.2083003002210972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18575,49,0.78 [0.44-1.37],0.3823171930073636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,17994,48,0.77 [0.52-1.12],0.1711271554454482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16006,37,0.89 [0.19-4.10],0.8824260468507283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15431,38,0.50 [0.29-0.87],0.0144060163158007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,15892,37,1.71 [1.09-2.69],0.0203534996350089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18471,49,0.99 [0.38-2.60],0.9823602089542206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18405,49,1.08 [0.55-2.11],0.8311303596293311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15431,38,1.31 [0.71-2.41],0.3807680968907179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18017,48,0.83 [0.53-1.28],0.3943434800871119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15460,36,1.38 [0.59-3.24],0.4581269283344783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18540,49,1.49 [0.49-4.48],0.480862534378434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",15961,38,0.90 [0.54-1.51],0.6962631324218125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15505,38,2.13 [1.24-3.68],0.006503574885111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18500,49,0.86 [0.47-1.57],0.6272247724180016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15631,36,1.01 [0.41-2.49],0.974862577800058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,15961,38,1.18 [0.48-2.89],0.7195323764217667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15607,36,0.72 [0.39-1.32],0.2884171973734066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16006,37,1.21 [0.23-6.32],0.8253440338084457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,15971,37,3.18 [0.62-16.31],0.1661361928216148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16006,37,1.18 [0.27-5.12],0.8206127422110011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18478,49,1.19 [0.36-3.95],0.7792927457028748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,17989,48,1.38 [0.86-2.23],0.1862078613953105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15575,36,0.67 [0.33-1.36],0.2649254154244738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15196,36,0.65 [0.27-1.57],0.3395302719174768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18453,48,1.84 [0.98-3.45],0.0586616039100168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16006,37,4.60 [0.82-25.89],0.0836907436711384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15626,36,1.12 [0.42-2.98],0.8236090600969908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,15954,38,1.60 [0.65-3.90],0.3032542270728701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16006,37,1.27 [0.45-3.59],0.6525130486350914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16003,38,1.30 [0.75-2.27],0.3461635856959228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,15929,37,1.29 [0.88-1.89],0.1941519629167201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18051,48,1.76 [1.13-2.72],0.0117326717081238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,17994,48,0.96 [0.39-2.35],0.9270901606160376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18321,48,0.90 [0.40-2.02],0.80057531643849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18190,50,1.10 [0.86-1.41],0.441598202996682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18584,48,1.02 [0.51-2.07],0.9507412894765424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18353,49,1.48 [1.04-2.10],0.0278794648580009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18616,50,1.46 [0.99-2.14],0.0546896350129757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18641,50,1.22 [0.44-3.40],0.700924257016293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18087,48,0.94 [0.71-1.27],0.7028276499340731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18353,49,1.03 [0.68-1.54],0.9032712441508406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15707,38,1.93 [1.21-3.09],0.0059091523585717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15505,38,1.55 [0.66-3.59],0.3117073151335455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18584,48,0.78 [0.44-1.38],0.396960955575664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15575,36,0.75 [0.42-1.31],0.3079561333356453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15499,37,0.99 [0.37-2.68],0.9918328256563496
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15460,36,1.09 [0.65-1.83],0.7515883865039633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15499,37,0.82 [0.46-1.47],0.5136489876981511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,15961,38,0.97 [0.67-1.40],0.8606956784841381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15604,36,0.93 [0.68-1.26],0.6273919966941618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15575,36,1.10 [0.51-2.35],0.8081823213958875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18321,48,1.87 [1.08-3.25],0.0259391052485002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18017,48,0.81 [0.32-2.08],0.6613407215055709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18233,48,1.30 [0.92-1.84],0.1315530536042987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,15954,38,1.09 [0.51-2.30],0.8257299064425991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18530,48,1.06 [0.83-1.36],0.627724582705697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15538,37,0.94 [0.61-1.45],0.7827195175074287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15460,36,1.07 [0.48-2.40],0.8701515155440447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,17994,48,0.83 [0.45-1.52],0.5415144961397407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15575,36,0.60 [0.29-1.25],0.1757963996781159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,15961,38,0.97 [0.72-1.31],0.8395988016742417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18349,50,0.99 [0.28-3.50],0.989137621256954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18297,47,1.39 [0.93-2.08],0.1076834910129863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,15926,38,1.27 [0.60-2.68],0.5345535729391115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,15954,38,0.86 [0.57-1.29],0.4585917290216011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18017,48,1.29 [0.80-2.08],0.2903007937243598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15575,36,0.75 [0.33-1.68],0.4825104934739703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18017,48,0.93 [0.64-1.36],0.7090614240192942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18017,48,0.92 [0.64-1.32],0.6343297302169764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18405,49,0.85 [0.58-1.25],0.4079458004358416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18641,50,1.09 [0.82-1.45],0.5375847492718913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15707,38,1.02 [0.84-1.22],0.8625454672585801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,15954,38,1.09 [0.75-1.57],0.6629846410459742
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18535,48,1.06 [0.71-1.59],0.7599372550839008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15505,38,1.25 [0.80-1.96],0.3323513952280724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15460,36,1.18 [0.69-2.03],0.5449993432802427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15771,38,1.33 [0.77-2.30],0.313598714708121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18392,50,1.04 [0.75-1.44],0.8338598217898696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15499,37,1.13 [0.86-1.49],0.3761109281021773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18584,48,0.76 [0.34-1.70],0.4971115565789854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15538,37,0.83 [0.42-1.63],0.5820741974032652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15460,36,1.04 [0.47-2.33],0.91582670247348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18261,48,1.07 [0.76-1.51],0.7026959446384576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,15954,38,1.52 [1.15-2.03],0.0036719825167394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,15926,38,0.69 [0.35-1.36],0.2810532130067505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15575,36,1.21 [0.40-3.61],0.73404188148474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,15961,38,0.84 [0.52-1.35],0.4717355275225877
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18412,50,0.78 [0.37-1.63],0.507965345455248
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15538,37,1.35 [0.83-2.17],0.223917549600508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18631,49,1.11 [0.57-2.18],0.7560824842290308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18604,49,0.93 [0.64-1.35],0.6981678116960506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18387,49,0.78 [0.41-1.51],0.4663164828475291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18641,50,1.17 [0.67-2.06],0.5792699901005826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18641,50,1.31 [0.77-2.22],0.3125601859272906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18353,49,1.07 [0.82-1.41],0.6198558093525772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18188,49,0.91 [0.63-1.34],0.646752786087951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18575,49,1.09 [0.90-1.32],0.3601563336856423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18227,48,1.04 [0.64-1.70],0.8700496801878397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18631,49,0.97 [0.72-1.30],0.827052911337967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18471,49,0.74 [0.37-1.49],0.4059638404285212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18193,48,0.84 [0.51-1.40],0.510802112796915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18471,49,1.03 [0.56-1.91],0.913820376605592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18450,49,1.14 [0.85-1.54],0.3824060876642073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18631,49,1.30 [0.78-2.17],0.3125322145229313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18405,49,1.00 [0.75-1.32],0.9778790300013154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18412,50,1.16 [0.77-1.75],0.482204023514494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18342,49,0.91 [0.58-1.43],0.6822895287727033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18405,49,0.94 [0.55-1.59],0.8061035122233202
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18413,49,1.06 [0.72-1.54],0.7771805202011806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18500,49,0.94 [0.73-1.21],0.6297177268570786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18405,49,1.35 [0.95-1.93],0.0943776244857239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18558,48,1.07 [0.70-1.64],0.7409069434702177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18295,48,0.83 [0.59-1.18],0.2972181912475626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18397,49,0.71 [0.45-1.13],0.1457561574169173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18604,50,1.11 [0.52-2.34],0.7935259456197401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18584,48,0.72 [0.36-1.45],0.355171428289088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18411,49,1.47 [0.77-2.81],0.2463875603302686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15707,38,0.72 [0.31-1.64],0.4294771681040223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15505,38,1.03 [0.74-1.42],0.8654675939604788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18261,48,1.31 [0.77-2.23],0.3102793037993465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,17994,48,1.05 [0.59-1.85],0.879918844543712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,15929,37,0.63 [0.34-1.16],0.1384480481102869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18411,49,0.51 [0.25-1.03],0.0611472135088709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18075,48,1.10 [0.58-2.06],0.7767725385516171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18631,49,1.19 [0.71-2.02],0.5106069750049272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18500,49,0.63 [0.34-1.17],0.1456681508702134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18411,49,1.07 [0.43-2.65],0.8920420622162645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15575,36,1.03 [0.43-2.45],0.9436711590060392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18379,49,1.29 [1.03-1.61],0.0271916430200054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18453,48,0.67 [0.24-1.86],0.4422969600229729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15460,36,1.24 [0.66-2.34],0.509732700593183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18405,49,1.34 [0.53-3.39],0.5422177467126841
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18339,49,1.04 [0.51-2.12],0.9172969238701454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,17982,48,1.07 [0.55-2.08],0.8338430223001502
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18460,50,0.61 [0.31-1.19],0.1468799272189993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18631,49,0.74 [0.40-1.38],0.3390334470353972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15505,38,1.01 [0.48-2.14],0.9720891429378664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18631,49,0.52 [0.21-1.32],0.1716399178763171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,15991,37,0.49 [0.23-1.04],0.0617671462641679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18453,48,0.92 [0.49-1.74],0.8026226614581842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18261,48,1.44 [0.71-2.93],0.3091099086031654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18380,48,0.85 [0.42-1.72],0.6518929281972629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,17994,48,0.73 [0.34-1.54],0.4095720097431519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18412,50,1.30 [0.89-1.90],0.1793187129119109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15631,36,0.80 [0.27-2.31],0.6741403722561214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18575,49,0.56 [0.26-1.19],0.1290609091846363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18530,48,1.23 [0.67-2.27],0.5019782640434369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18584,48,0.91 [0.60-1.38],0.6644613457312161
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18411,49,0.98 [0.49-1.93],0.9473457308751004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18321,48,1.78 [0.83-3.80],0.1371858111570071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18453,48,1.63 [1.13-2.36],0.009362709290564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18515,49,0.98 [0.34-2.81],0.9754790839097937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15505,38,0.96 [0.48-1.92],0.9080788839192314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18321,48,1.02 [0.46-2.26],0.9622905018694096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15499,37,1.55 [0.80-2.99],0.1910287384280915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15707,38,1.01 [0.43-2.37],0.9853259013100156
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15505,38,1.22 [0.95-1.56],0.1207160774660963
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18373,49,0.84 [0.34-2.08],0.7112529049646141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18392,49,0.84 [0.49-1.42],0.5086159961224193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18631,49,0.93 [0.68-1.28],0.6745220020213787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18333,49,1.20 [0.50-2.88],0.6812247311932274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18450,49,0.64 [0.27-1.50],0.3002201554819214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18558,48,0.76 [0.35-1.65],0.488894812265745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17794,49,0.82 [0.30-2.21],0.691417962127882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18346,48,0.75 [0.17-3.18],0.692090628795238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17770,45,1.74 [0.61-4.96],0.2966217724380902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,15938,37,1.15 [0.60-2.23],0.6679052385653004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18598,49,0.65 [0.40-1.05],0.0800939920570275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18227,48,0.99 [0.59-1.64],0.9557525658268454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18319,49,1.01 [0.76-1.35],0.9504142482287512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15478,38,1.25 [0.63-2.47],0.5296508377820818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18405,49,0.68 [0.38-1.21],0.1911412836096547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15631,36,1.19 [0.55-2.59],0.6609733169053622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18575,49,1.21 [0.58-2.54],0.6074524969064827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18631,49,1.29 [0.74-2.26],0.3727210818956489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,15983,38,1.11 [0.44-2.82],0.8240604659626679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15707,38,1.06 [0.49-2.25],0.8878923740122403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18405,49,1.28 [0.61-2.68],0.5178960510411381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18405,49,0.60 [0.27-1.32],0.2033130548595559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,15929,37,1.07 [0.36-3.14],0.9079469698078276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18575,49,0.84 [0.51-1.39],0.5090150360523895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17743,48,1.17 [0.51-2.68],0.7086698366998843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18411,49,1.74 [0.50-6.04],0.38532022197239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18411,49,1.17 [0.42-3.30],0.7623392931269886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,15962,38,2.11 [1.33-3.35],0.0015375411825779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,15954,38,1.63 [0.58-4.57],0.3553997738092265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15431,38,1.08 [0.68-1.71],0.732696125622175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15431,38,0.97 [0.43-2.18],0.9374965203649288
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,15891,37,0.93 [0.59-1.49],0.7760615199542313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,17994,48,0.90 [0.58-1.41],0.6466004680424271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18453,48,1.02 [0.75-1.39],0.8810324073771845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,15929,37,0.94 [0.69-1.30],0.7231587224707483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18261,48,0.98 [0.61-1.57],0.9378299825178325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17816,48,0.99 [0.51-1.91],0.9777384389941962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18547,49,0.72 [0.48-1.08],0.1168502383780641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18412,50,1.02 [0.70-1.47],0.9338022720366232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18412,50,0.70 [0.34-1.44],0.3322422036553005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15707,38,1.48 [0.56-3.87],0.4286904829217655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,15954,38,2.61 [1.20-5.68],0.0159912358144478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18575,49,1.36 [0.69-2.69],0.3737747246859197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15499,37,1.19 [0.64-2.22],0.5841995029190987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18641,50,0.53 [0.22-1.26],0.1508186286202754
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18412,50,0.61 [0.31-1.19],0.1459160778836064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18017,48,0.63 [0.31-1.26],0.19199767138255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18321,48,0.77 [0.53-1.14],0.1941661537870281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18412,50,0.99 [0.52-1.89],0.973220001307759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15431,38,1.10 [0.46-2.61],0.8259035555769971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,15961,38,1.09 [0.66-1.78],0.74344817662649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15499,37,1.20 [0.70-2.05],0.500773178902971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18321,48,0.94 [0.74-1.20],0.6400618028076301
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18321,48,1.07 [0.81-1.40],0.6541336180075663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18321,48,1.67 [0.99-2.81],0.052471361065544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18411,49,0.49 [0.19-1.26],0.1412207785020563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18580,49,1.53 [0.86-2.72],0.1471319637092474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18425,47,0.94 [0.26-3.40],0.9284581353441717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,15929,37,1.21 [0.82-1.77],0.3409553725473014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15707,38,0.65 [0.34-1.25],0.1999701463390539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,15929,37,0.68 [0.31-1.50],0.3460343855936054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15707,38,1.57 [0.92-2.69],0.0981871280994025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18405,49,0.80 [0.58-1.11],0.1809631766294885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,17994,48,0.92 [0.52-1.62],0.7687154080561283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17759,48,0.88 [0.57-1.36],0.5659328779376809
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,15991,37,0.78 [0.35-1.75],0.5509251567805394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18087,48,1.45 [0.89-2.35],0.132387579506356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15505,38,1.26 [0.62-2.54],0.5259561592638793
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18087,48,1.49 [0.81-2.75],0.1966806686122983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,15991,37,0.91 [0.56-1.49],0.7064667848290447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18610,50,0.79 [0.52-1.20],0.2597431413852626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15631,36,1.37 [0.45-4.16],0.5807630108844276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15505,38,1.14 [0.43-3.00],0.7882413169468402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15499,37,0.91 [0.50-1.66],0.7623426035573737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15707,38,1.24 [0.73-2.12],0.4273862171008169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15707,38,1.22 [0.84-1.77],0.2961589802565444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15460,36,0.85 [0.38-1.92],0.6967808711005581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15431,38,0.94 [0.44-1.99],0.8663632379176068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18105,49,1.08 [0.74-1.56],0.7010360511310292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15538,37,0.94 [0.61-1.45],0.7749422660869733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,17994,48,1.10 [0.78-1.54],0.5855230948746455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15707,38,0.63 [0.30-1.31],0.2138064709451043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15431,38,0.79 [0.33-1.93],0.6103367322488402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,17947,48,1.45 [1.02-2.07],0.0381186660080795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,17994,48,0.93 [0.62-1.40],0.7351767212317442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18017,48,0.94 [0.62-1.43],0.77071590680583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18455,49,1.10 [0.82-1.47],0.5419111341045596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18321,48,0.96 [0.60-1.53],0.8690634779355725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18321,48,0.79 [0.52-1.19],0.2618743672343095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18017,48,0.90 [0.61-1.32],0.5821481510495958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,15929,37,0.92 [0.61-1.38],0.6784132190636182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15736,37,1.30 [0.49-3.46],0.6014940349158836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,17994,48,0.84 [0.47-1.50],0.5514294914982734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16006,37,2.72 [1.02-7.21],0.0451290156786378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15108,37,1.76 [0.46-6.76],0.4124508418739956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,15892,37,0.90 [0.53-1.54],0.713544512655959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,15972,37,0.79 [0.52-1.19],0.2607539555411472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15805,38,1.17 [0.54-2.54],0.6955692512345886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16006,37,2.79 [0.56-13.95],0.2102840418669211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16006,37,0.74 [0.16-3.42],0.7023108658770745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18411,49,1.23 [0.84-1.81],0.2881492069740552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16003,38,3.17 [1.56-6.42],0.0013648916285603
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15575,36,1.90 [1.17-3.09],0.0096314658476224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18412,50,0.85 [0.47-1.54],0.5942112162991009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,17994,48,1.21 [0.79-1.83],0.3779344504892417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15631,36,0.54 [0.28-1.06],0.0731850301848398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",15954,38,1.12 [0.54-2.31],0.763909139385789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,15926,38,0.50 [0.14-1.79],0.2871238758748666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18087,48,1.27 [0.59-2.74],0.5451111419872836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,15991,37,1.16 [0.84-1.61],0.3603317600674246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18524,48,1.57 [0.87-2.85],0.1356853490788188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18038,49,0.88 [0.64-1.22],0.4467410048807423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18497,48,0.90 [0.79-1.02],0.101652961191716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18473,49,0.78 [0.32-1.89],0.5869931403878714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15575,36,0.78 [0.45-1.36],0.3798568300712448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18261,48,1.14 [0.82-1.58],0.4398741808852588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,15983,38,0.92 [0.53-1.58],0.7526017219460918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15499,37,0.85 [0.53-1.38],0.5180208635869759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18450,49,0.77 [0.37-1.60],0.4765132668760471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18412,50,0.87 [0.50-1.50],0.6112497186558126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15575,36,1.20 [0.54-2.67],0.6563144931611724
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18453,48,1.11 [0.73-1.67],0.6359779208388403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,15991,37,0.75 [0.44-1.27],0.2816915097492763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15707,38,1.73 [1.13-2.66],0.0121403165963972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,15929,37,0.98 [0.71-1.36],0.9070312250590392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15575,36,1.39 [0.78-2.47],0.261798970378472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18540,49,1.08 [0.44-2.64],0.8684516463602664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,15991,37,0.89 [0.51-1.55],0.6855490433570979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18327,48,0.89 [0.60-1.31],0.5609180641140532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15431,38,0.88 [0.55-1.38],0.5674863241424821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18383,50,1.10 [0.76-1.57],0.614639663427504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18261,48,1.35 [0.67-2.73],0.4073198130270686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18383,49,1.29 [0.76-2.20],0.3477037160396764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15505,38,1.31 [0.30-5.79],0.7194683783229786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18411,49,1.01 [0.46-2.24],0.9787357474965316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18087,48,0.91 [0.42-1.98],0.8195489430640908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18575,49,0.93 [0.71-1.22],0.6054524116063337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15575,36,0.83 [0.41-1.69],0.6116239296038173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15647,36,0.59 [0.12-2.90],0.5172590295651859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18405,49,1.03 [0.50-2.10],0.9444897605900312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18405,49,0.66 [0.39-1.11],0.1144809122515239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18405,49,0.85 [0.56-1.29],0.4389223554846757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18405,49,1.56 [0.74-3.32],0.2458875388524271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,15969,37,0.72 [0.38-1.37],0.3120994313737789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18352,50,1.76 [0.80-3.84],0.1581423380704475
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,17994,48,1.10 [0.63-1.91],0.7422259657601253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18631,49,1.09 [0.69-1.71],0.7209231985508743
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15575,36,1.19 [0.61-2.31],0.6151849594248633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15575,36,0.89 [0.31-2.62],0.8391199117736575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15431,38,1.03 [0.55-1.93],0.9301165913994414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18405,49,0.93 [0.75-1.16],0.5321071179269543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18584,48,1.71 [0.55-5.30],0.3521719840086823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15575,36,0.90 [0.34-2.35],0.8267165557903513
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18233,48,1.03 [0.79-1.34],0.8468643386006057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18373,49,1.14 [0.80-1.60],0.4705031580612198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,17989,48,1.02 [0.51-2.05],0.9578046350441042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18017,48,0.90 [0.53-1.52],0.6925760854652134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18631,49,0.74 [0.38-1.47],0.3943891317941628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,15954,38,0.73 [0.26-2.08],0.5553576815943034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18087,48,1.09 [0.63-1.88],0.7661665413174823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16006,37,0.49 [0.08-3.00],0.4423332999611822
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18377,49,0.60 [0.34-1.08],0.0881874129843084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,15983,38,0.95 [0.67-1.34],0.7728910722977135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,15926,38,1.12 [0.77-1.61],0.5588219419923365
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18500,49,1.48 [0.81-2.70],0.1969575719690304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15499,37,1.29 [0.85-1.96],0.236427673899173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15510,37,1.04 [0.69-1.55],0.866193629979542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18087,48,1.34 [1.01-1.78],0.0392647600627299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18321,48,0.92 [0.66-1.30],0.6464823184662305
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18412,50,1.03 [0.82-1.30],0.7711746486662554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15499,37,2.01 [0.98-4.09],0.055873745434552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18641,50,0.50 [0.22-1.16],0.1078604861345824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18584,48,1.52 [0.87-2.66],0.1381186897255535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18411,49,0.85 [0.34-2.13],0.7253081653874579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18411,49,0.68 [0.23-1.97],0.47307580775383
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18459,48,0.80 [0.39-1.63],0.5364551924569197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18405,49,0.76 [0.41-1.40],0.3803257621091671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15575,36,1.07 [0.81-1.41],0.6366765204044869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,15983,38,1.00 [0.51-1.98],0.9996376654896711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,15991,37,1.79 [0.58-5.56],0.313983393512408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18484,48,1.92 [0.66-5.60],0.2326173708886247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18641,50,0.61 [0.20-1.83],0.3765106171214947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,15929,37,0.84 [0.50-1.41],0.5137296941372862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15575,36,0.72 [0.46-1.11],0.133741277624726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15538,37,0.71 [0.46-1.10],0.1240682197983897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,15991,37,1.68 [0.46-6.19],0.4340752356445737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18412,50,0.45 [0.23-0.89],0.0218132269197831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15678,38,1.29 [0.69-2.40],0.4200372767872714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15631,36,0.69 [0.29-1.64],0.4014665887708774
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18641,50,1.31 [0.66-2.58],0.4373721106625794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18405,49,0.83 [0.46-1.51],0.5497209505194192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15707,38,0.77 [0.34-1.74],0.5336295422501023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18380,48,1.09 [0.42-2.84],0.8618530119001061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15538,37,0.99 [0.58-1.68],0.975068333232024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,15926,38,1.08 [0.51-2.30],0.8464853174755111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18240,49,1.43 [0.67-3.05],0.3621759138794078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,17890,48,1.26 [0.92-1.71],0.1503361423536146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15460,36,0.74 [0.34-1.62],0.4475631087203994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18017,48,0.50 [0.24-1.04],0.0633344219668516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15538,37,1.00 [0.48-2.07],0.99439226621281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18049,49,1.15 [0.88-1.49],0.2979548392416009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15499,37,1.50 [0.73-3.08],0.267980434050969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18321,48,0.80 [0.54-1.18],0.2626704104722751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,15983,38,0.67 [0.25-1.81],0.4281700735954948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18641,50,1.07 [0.73-1.57],0.7388089871426091
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18522,49,1.15 [0.79-1.66],0.4606872035800549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15331,36,1.07 [0.51-2.27],0.8585316028822166
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18641,50,1.10 [0.74-1.63],0.6481984068537099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,15981,37,0.92 [0.23-3.73],0.9029938972950586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18424,48,0.76 [0.42-1.38],0.3699591320222766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15431,38,0.34 [0.11-1.02],0.0547882882124952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18488,48,0.60 [0.28-1.31],0.2007844822786125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15505,38,0.51 [0.15-1.76],0.2854910599265504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18575,49,1.04 [0.71-1.52],0.8583627702601738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,15964,37,0.38 [0.20-0.70],0.0021937517924887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15460,36,1.36 [0.69-2.67],0.3697131862458882
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18549,48,1.08 [0.58-2.03],0.8012329785758939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18453,48,0.67 [0.46-0.99],0.0442185449821708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,15983,38,1.49 [0.45-4.88],0.5105267266391356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,15947,38,0.70 [0.29-1.73],0.4459232184318858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18500,49,0.74 [0.43-1.28],0.2843436019246789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,17994,48,1.04 [0.77-1.40],0.8166193085795137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18233,48,1.14 [0.80-1.60],0.4703452777656285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15431,38,0.74 [0.38-1.44],0.3720010053264307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15431,38,0.94 [0.28-3.18],0.9257042572867468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18168,48,0.62 [0.32-1.22],0.1660805361571267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15631,36,0.94 [0.39-2.27],0.8943720214875341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18450,49,1.03 [0.64-1.68],0.8926134938813718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,17968,48,0.87 [0.64-1.19],0.3890089560360548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18380,48,0.87 [0.34-2.25],0.775904311930594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18087,48,1.10 [0.74-1.64],0.6325586398473846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18471,49,0.93 [0.27-3.25],0.909811585523314
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18261,48,1.18 [0.61-2.26],0.6233491547316564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18584,48,1.02 [0.63-1.66],0.92254812663935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,15849,38,1.32 [0.41-4.22],0.6393073365049766
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18416,49,1.01 [0.79-1.28],0.953996205585492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18471,49,1.06 [0.38-2.94],0.9097602778440252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,17888,46,0.79 [0.54-1.16],0.2363056157045291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18641,50,0.89 [0.40-1.96],0.7678778224072154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18261,48,1.17 [0.71-1.95],0.5373144975702706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15575,36,0.80 [0.38-1.68],0.5577703447834249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18087,48,0.90 [0.68-1.19],0.4652345793914272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,15983,38,0.94 [0.58-1.52],0.7990513156556889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,15954,38,0.83 [0.47-1.46],0.5074943755625991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,15954,38,1.04 [0.76-1.43],0.802689607198771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15499,37,1.23 [0.86-1.76],0.2576796435042729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15538,37,1.02 [0.72-1.46],0.8992078567130835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15460,36,1.05 [0.82-1.35],0.6983006768907194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18471,49,1.26 [0.49-3.22],0.6348087108571661
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16003,38,0.78 [0.35-1.73],0.5406712323615418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15460,36,0.84 [0.33-2.12],0.7158015749201885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18261,48,0.89 [0.59-1.37],0.6078442714507768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15505,38,0.73 [0.35-1.51],0.3947309898326627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18105,49,1.34 [0.82-2.20],0.2394120767001988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15505,38,0.41 [0.13-1.33],0.1390343253686399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16003,38,1.93 [0.74-5.03],0.1799796931499213
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15505,38,0.85 [0.51-1.44],0.5575097061107339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,15961,38,1.44 [0.73-2.84],0.2890671313321989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,15991,37,0.39 [0.16-0.94],0.0368799892557863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15499,37,1.40 [0.87-2.25],0.1694222769650631
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15460,36,1.12 [0.83-1.50],0.4682178100474787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,13880,31,1.34 [0.98-1.84],0.0671853231091194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18465,49,1.93 [0.86-4.35],0.1134576553082578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18030,47,1.13 [0.71-1.80],0.600521380144053
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,17937,48,1.80 [1.08-3.00],0.0233402039630902
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18413,49,0.94 [0.70-1.25],0.659332730953343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18160,48,1.83 [1.09-3.09],0.0225039357517794
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15680,38,0.87 [0.45-1.67],0.6713667810213078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15782,38,0.44 [0.19-1.03],0.059006073995565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18087,48,0.99 [0.73-1.34],0.9371759531699858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,15991,37,0.48 [0.16-1.48],0.2019253646439659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,15991,37,1.15 [0.45-2.92],0.7706720294378979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15499,37,1.65 [0.98-2.80],0.0619869913377916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18411,49,1.05 [0.68-1.62],0.8192598511184032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18381,49,0.91 [0.62-1.34],0.6341770062281866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,15954,38,0.86 [0.56-1.34],0.5067231595532564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18417,49,0.83 [0.50-1.37],0.4676338605739049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18347,49,0.70 [0.39-1.26],0.2370566028613782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17233,48,0.80 [0.40-1.58],0.515652639662666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15631,36,1.15 [0.63-2.12],0.6439597293801096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18453,48,0.57 [0.30-1.09],0.0870061019785784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18025,48,0.66 [0.48-0.91],0.0112214186639864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18412,50,1.93 [0.72-5.17],0.1907125751501295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18631,49,1.23 [0.55-2.77],0.6174611159335535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14531,38,1.37 [0.37-5.11],0.6374058496430419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18515,48,1.76 [1.04-2.95],0.0335182043731328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18442,49,0.88 [0.39-1.95],0.7484378109650465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15575,36,0.93 [0.39-2.23],0.8686572054935837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15838,37,1.33 [0.92-1.93],0.1260598996761606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18261,48,1.39 [0.65-2.95],0.3972051572644102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18405,49,1.40 [0.86-2.28],0.1703835300592797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18361,49,1.06 [0.81-1.38],0.6655979393706923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18471,49,1.17 [0.81-1.68],0.4034686248290099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18575,49,0.85 [0.60-1.20],0.3515999091409206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18105,49,0.88 [0.46-1.69],0.6929653664172708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18575,49,1.00 [0.64-1.56],0.9869587557032828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18105,49,1.28 [0.91-1.79],0.1570386357931881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18610,50,1.09 [0.37-3.20],0.8808857828710697
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18631,49,0.71 [0.39-1.31],0.270393800508287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18392,49,1.10 [0.84-1.44],0.4788821982476294
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18350,50,1.11 [0.88-1.38],0.375071863968562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18631,49,1.33 [0.96-1.85],0.0854660564985705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18304,48,1.13 [0.80-1.59],0.4818572471880261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18471,49,1.20 [0.84-1.72],0.3187384561852595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15431,38,0.97 [0.61-1.52],0.8840930139145666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15765,37,0.99 [0.55-1.77],0.973437290014415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15460,36,1.30 [1.01-1.68],0.0409352212922856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15431,38,1.04 [0.69-1.57],0.864968438100044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,15991,37,2.23 [0.69-7.27],0.1820385469789943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15631,36,0.82 [0.55-1.23],0.3388985756844879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18584,48,1.00 [0.80-1.26],0.9997637308747084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18471,49,0.81 [0.47-1.40],0.4495296764982938
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15505,38,1.02 [0.60-1.75],0.9401080310480034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15505,38,1.11 [0.66-1.84],0.7013390774920176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18405,49,1.03 [0.83-1.27],0.7931060976252066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18233,48,1.04 [0.73-1.48],0.8459453449658133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,15982,38,0.85 [0.68-1.07],0.1701598648841004
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18323,48,1.04 [0.74-1.44],0.8377017356917806
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15505,38,0.92 [0.48-1.75],0.7964647434188225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18471,49,1.05 [0.80-1.38],0.7469240821189898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18453,48,1.42 [0.70-2.91],0.3334868981658357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15575,36,1.31 [0.37-4.56],0.6764756307175575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15431,38,0.53 [0.30-0.95],0.0342746078740295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15431,38,1.14 [0.43-3.05],0.7879909510273126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18087,48,0.54 [0.17-1.74],0.3010925169306467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15631,36,0.89 [0.64-1.25],0.5154945318435649
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18584,48,1.06 [0.71-1.58],0.7602554320502759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18321,48,1.15 [0.88-1.49],0.3120305252533459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18017,48,0.90 [0.62-1.32],0.6004172634355162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18412,50,0.99 [0.44-2.22],0.9845856414114752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15499,37,1.02 [0.68-1.54],0.9244193365226854
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15431,38,1.08 [0.75-1.57],0.6665523612110003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18453,48,1.00 [0.62-1.61],0.9924582286387218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15460,36,0.81 [0.33-2.02],0.6538773988299407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18321,48,0.96 [0.54-1.73],0.8993306756917244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18392,50,0.94 [0.55-1.62],0.8327294586130277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,15961,38,1.14 [0.71-1.83],0.5812342009453075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15631,36,1.23 [0.81-1.86],0.3273040182897212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18575,49,0.78 [0.26-2.36],0.6569414539680769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,15991,37,1.39 [0.68-2.84],0.3619882891024708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,15929,37,1.23 [0.71-2.13],0.4677548046795875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15575,36,1.42 [0.69-2.93],0.3467628900209516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15505,38,1.25 [0.37-4.27],0.7178713100518418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15505,38,1.35 [0.91-2.00],0.1406081356199916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15575,36,1.27 [0.58-2.75],0.5474709181017254
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,17994,48,1.06 [0.68-1.64],0.8048246726404968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18405,49,0.94 [0.72-1.22],0.6288807792518115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18069,49,1.62 [1.15-2.30],0.0062571213421703
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15398,38,1.10 [0.55-2.22],0.7876491876202636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15499,37,1.39 [0.88-2.19],0.1544241375814434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15499,37,1.10 [0.74-1.63],0.6335510137432685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15499,37,0.52 [0.22-1.26],0.1498404483796453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18126,48,1.00 [0.84-1.20],0.9685295782358396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15460,36,0.86 [0.41-1.82],0.6904575555298824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15505,38,1.34 [0.85-2.11],0.2018060725740561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18631,49,1.08 [0.74-1.57],0.6947033575537471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15499,37,1.66 [1.07-2.56],0.0225825232222303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15505,38,1.11 [0.63-1.96],0.7123788542934544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18105,49,1.43 [0.75-2.76],0.2795997660006508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15460,36,0.58 [0.25-1.35],0.2051691360400183
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,15926,38,1.35 [0.73-2.50],0.334782388165262
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,15954,38,0.89 [0.44-1.79],0.7419788265163557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18352,50,1.00 [0.79-1.25],0.9798708492956668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15575,36,2.29 [1.59-3.30],9.242715841930134e-06
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15631,36,0.50 [0.18-1.40],0.1866226594761491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18575,49,0.82 [0.54-1.26],0.3656956669048845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18641,50,1.47 [0.63-3.40],0.3695091941709173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18228,48,1.22 [0.71-2.08],0.4676316907488494
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18321,48,0.91 [0.68-1.22],0.5324105662908719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,15954,38,0.96 [0.62-1.49],0.8575970396748518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,15961,38,1.30 [0.84-1.99],0.2342628466488825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18641,50,1.29 [0.83-1.99],0.252915776585801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18453,48,0.97 [0.41-2.29],0.9409343696937652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15538,37,1.08 [0.82-1.41],0.5978928562149455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15538,37,0.80 [0.38-1.65],0.5371111094316923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15538,37,0.74 [0.44-1.25],0.2590380981095265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15431,38,0.97 [0.48-1.96],0.925417600210966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18573,49,1.01 [0.74-1.37],0.969142225430498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,15954,38,1.18 [0.77-1.82],0.4430581361614997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18321,48,1.10 [0.82-1.49],0.5233267955003214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,15929,37,1.04 [0.64-1.68],0.8885582231773574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15631,36,1.20 [0.66-2.17],0.5482484415120299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15489,36,0.95 [0.65-1.40],0.8029715237586489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18087,48,1.10 [0.72-1.68],0.665838243483267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,15954,38,1.14 [0.53-2.46],0.7336403994267788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15538,37,0.87 [0.59-1.29],0.4976876613528269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,15929,37,1.22 [0.81-1.83],0.3414845387215859
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18352,49,1.48 [0.56-3.91],0.4293169567562064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15499,37,0.97 [0.65-1.44],0.8634320581652731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,15929,37,0.91 [0.70-1.20],0.5176765395579481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,15961,38,1.64 [1.06-2.54],0.0273447742814501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18261,48,0.95 [0.61-1.47],0.8222316637309323
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,15954,38,0.99 [0.57-1.72],0.9825009205097124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18437,49,1.35 [0.83-2.21],0.2233561742336408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15575,36,1.34 [0.71-2.53],0.3631142880704874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15499,37,1.02 [0.79-1.33],0.8584895235728569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,15954,38,1.05 [0.84-1.33],0.6594738563184332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18412,50,1.06 [0.86-1.29],0.6030678078544917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18233,48,1.19 [0.68-2.09],0.5418839764205283
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18321,48,0.82 [0.35-1.93],0.6476717244752883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18405,49,1.04 [0.52-2.08],0.9153462952709198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18093,49,1.28 [0.50-3.26],0.6046302517725675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18321,48,1.10 [0.52-2.34],0.7965492829031757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18273,50,0.84 [0.56-1.26],0.3911804693211899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18641,50,1.67 [0.59-4.68],0.3304928067398971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18533,48,1.01 [0.66-1.54],0.9539899239502548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18261,48,1.17 [0.64-2.15],0.6036886601332414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18321,48,0.92 [0.58-1.45],0.7188400824365824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18182,49,1.03 [0.49-2.16],0.9390918184075312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,15961,38,1.65 [0.70-3.85],0.2504220583227554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18411,49,2.21 [0.90-5.44],0.0847889253412567
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18525,48,1.39 [0.67-2.90],0.3754877688068671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18256,48,1.17 [0.69-1.98],0.5706040117875828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15631,36,0.87 [0.60-1.26],0.4666158386577557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15888,38,1.13 [0.58-2.21],0.7162092602067984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15575,36,1.21 [0.78-1.88],0.3920954980669232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18321,48,1.22 [0.42-3.51],0.7145226905864203
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,15983,38,1.14 [0.72-1.80],0.5874044705658396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18087,48,1.13 [0.82-1.54],0.457142621335561
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,15926,38,1.24 [0.62-2.50],0.5394153702363045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15575,36,1.04 [0.65-1.67],0.8675198116466534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18017,48,0.82 [0.58-1.16],0.251732106350871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",15929,37,1.03 [0.76-1.40],0.8245543378999076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,15954,38,1.14 [0.58-2.25],0.6983769602381654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,15926,38,1.27 [0.74-2.17],0.3902916246423541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15575,36,0.89 [0.57-1.37],0.5814754944159125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,15926,38,0.69 [0.33-1.45],0.327363633610208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18261,48,0.96 [0.73-1.26],0.7632896879711811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18561,48,0.53 [0.22-1.25],0.1452855578606879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18017,48,0.64 [0.31-1.33],0.2331559840701718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",15983,38,0.92 [0.59-1.42],0.7050726008232133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15538,37,0.78 [0.55-1.10],0.1514983760210745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15460,36,0.85 [0.48-1.50],0.5693461283571346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15585,36,0.94 [0.40-2.20],0.8784755599868892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15499,37,1.13 [0.66-1.92],0.6585676279356025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18584,48,0.93 [0.50-1.74],0.8283676392689647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18405,49,0.94 [0.71-1.25],0.6806448205054032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,15926,38,1.22 [0.75-1.98],0.424162589740271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15460,36,0.49 [0.16-1.51],0.2126284779454594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,15961,38,1.29 [0.90-1.85],0.160058142873406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18087,48,0.32 [0.15-0.72],0.0054142906470729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15538,37,0.52 [0.17-1.56],0.2460016711523116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15505,38,0.74 [0.31-1.75],0.4966029296718345
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,15983,38,1.06 [0.75-1.48],0.7455163541406137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,15929,37,1.67 [0.74-3.80],0.2175761170262751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15707,38,0.75 [0.29-1.91],0.5429827139086978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18470,49,1.29 [0.59-2.82],0.5269095720694641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,15961,38,1.06 [0.44-2.53],0.8952942679077428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18379,48,1.32 [0.56-3.12],0.528006820347256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18227,48,1.23 [0.54-2.79],0.6217471350544419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15575,36,1.29 [0.84-1.97],0.2388090567125315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18361,49,0.91 [0.72-1.16],0.4484809920296227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,17994,48,0.55 [0.27-1.14],0.1069685504014211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,15929,37,0.30 [0.10-0.89],0.0297352410228186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18641,50,2.82 [0.59-13.51],0.1945946522981797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18405,49,0.89 [0.54-1.48],0.6498310791902688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,15983,38,0.95 [0.62-1.45],0.801716571879018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15538,37,1.01 [0.77-1.33],0.9152369269232276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",15954,38,0.96 [0.55-1.70],0.891701345714916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",15873,37,1.02 [0.76-1.36],0.9117806909310112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15460,36,0.77 [0.44-1.35],0.3655068140206592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15538,37,0.99 [0.48-2.07],0.9848847388912108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18261,48,1.15 [0.73-1.84],0.546768919658609
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15505,38,1.03 [0.73-1.47],0.8510110738542289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18412,50,1.37 [0.95-1.96],0.0880031800898696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18631,49,0.99 [0.76-1.28],0.9236601800087064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,15961,38,0.73 [0.44-1.24],0.2447910197789373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15460,36,1.43 [0.82-2.51],0.2109798939105864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18105,49,1.30 [0.65-2.59],0.4513112514873598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,15961,38,1.11 [0.77-1.60],0.5856062091061722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15499,37,0.89 [0.59-1.34],0.5686293712368452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELN,Elastin,15983,38,1.31 [0.53-3.23],0.5547500003589683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18321,48,1.05 [0.67-1.65],0.8153262631550505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15460,36,0.51 [0.18-1.40],0.1915777897780504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18105,49,0.92 [0.54-1.58],0.7673039085326847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14747,36,1.36 [0.79-2.36],0.269994973749583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18641,50,0.41 [0.10-1.74],0.2260264195622221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18396,49,1.00 [0.72-1.38],0.9916430979739538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18575,49,1.04 [0.71-1.54],0.8325998203448264
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15538,37,0.98 [0.58-1.64],0.9262101430679054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,15926,38,0.80 [0.44-1.48],0.4832325484873659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15460,36,0.86 [0.26-2.86],0.7999278982458525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15460,36,1.21 [0.66-2.22],0.5293397452240636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18641,50,0.61 [0.21-1.75],0.3575297455695352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18471,49,1.15 [0.63-2.12],0.6464945621599518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15538,37,0.92 [0.38-2.24],0.852604150021407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17828,46,0.77 [0.56-1.06],0.1104103035439503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,15926,38,0.79 [0.42-1.50],0.4750105043663869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,17994,48,0.58 [0.34-0.99],0.0455025822902439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18087,48,1.25 [0.38-4.12],0.7113868713915257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18087,48,0.67 [0.29-1.51],0.3310034912890066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15538,37,1.06 [0.64-1.76],0.8293795505969387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15505,38,1.28 [0.50-3.26],0.6056520695587442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15575,36,1.20 [0.79-1.81],0.3858392984821263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18376,49,1.16 [0.89-1.50],0.2813953101421834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,15926,38,0.96 [0.47-1.93],0.8986930775002799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18437,49,0.89 [0.40-1.99],0.782226850674786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18017,48,1.06 [0.73-1.53],0.7756733920377679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17768,47,1.03 [0.44-2.38],0.9501934482130092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15631,36,0.70 [0.23-2.13],0.5356646587425045
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18641,50,1.05 [0.39-2.84],0.9214469470557204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18233,48,1.28 [0.58-2.84],0.5434418379768423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18087,48,0.62 [0.36-1.05],0.0728537942866915
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15707,38,0.94 [0.45-1.99],0.8723098843961807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18405,49,1.01 [0.71-1.43],0.9692216287806524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15538,37,1.06 [0.68-1.65],0.806389033456575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18556,48,0.73 [0.31-1.77],0.4905352793626557
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18453,48,0.61 [0.22-1.66],0.3306270335718827
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18319,49,2.19 [0.66-7.27],0.2017052953698381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18453,48,0.88 [0.30-2.60],0.8153378478012606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18321,48,0.94 [0.73-1.20],0.597968354473535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15575,36,1.07 [0.72-1.60],0.7382640224015851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15431,38,0.58 [0.20-1.69],0.3160844843659083
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18233,48,0.92 [0.66-1.29],0.6424906703903293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15707,38,1.02 [0.41-2.56],0.9683884214201898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15505,38,1.15 [0.57-2.32],0.6902788330211105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,15926,38,0.91 [0.39-2.14],0.8267089199617645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15631,36,0.93 [0.71-1.22],0.5969024024734466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18295,48,1.99 [0.76-5.24],0.1616197693355141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15460,36,0.85 [0.38-1.90],0.6966537419229082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18641,50,1.08 [0.50-2.34],0.8462680320578483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18380,48,0.84 [0.40-1.78],0.6479062934824913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15431,38,0.91 [0.49-1.69],0.7731603851803674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15505,38,1.23 [0.79-1.93],0.3579949006267132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,15954,38,1.00 [0.69-1.46],0.989215111252511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15431,38,0.40 [0.14-1.19],0.0988504458461517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15505,38,1.03 [0.73-1.46],0.8488626289021466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15707,38,1.51 [0.70-3.28],0.2917016376658752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15460,36,0.83 [0.43-1.60],0.5743187672182242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15460,36,0.84 [0.40-1.78],0.6493598074529408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18575,49,0.48 [0.16-1.45],0.1940131954528617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16003,38,1.53 [0.76-3.11],0.2348127878111188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15781,37,1.54 [0.81-2.91],0.1858203634697308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18411,49,0.80 [0.50-1.28],0.3505568636288222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16006,37,1.48 [0.65-3.37],0.3459548641009481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,15938,37,1.39 [0.41-4.78],0.596461511271525
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16006,37,2.89 [0.38-21.79],0.303652922368922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18450,49,0.83 [0.53-1.30],0.4120617729125049
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18464,48,3.95 [1.57-9.90],0.0034332590292559
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18471,49,2.36 [1.01-5.53],0.0478425335302
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18478,49,0.52 [0.13-1.99],0.336173594142991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18380,48,1.00 [0.76-1.32],0.9917624167878392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18412,50,0.93 [0.68-1.29],0.6727392100636675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",15983,38,1.19 [0.69-2.04],0.5371100569776629
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18641,50,0.88 [0.53-1.48],0.6346721175591119
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18515,49,1.23 [0.85-1.77],0.2659294097554581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18057,48,0.86 [0.53-1.40],0.5490750506571036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18405,49,0.98 [0.62-1.55],0.9278041167584796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18412,50,1.12 [0.81-1.55],0.4966470659607608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,15929,37,1.05 [0.66-1.67],0.8369932220109626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,15961,38,1.12 [0.94-1.34],0.2020505461100687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,15926,38,0.57 [0.14-2.21],0.4134225210607177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15538,37,1.24 [0.75-2.07],0.4037712130626008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,15983,38,0.52 [0.17-1.62],0.257981902844093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18321,48,1.33 [0.62-2.85],0.4699827984407989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18392,50,1.38 [0.61-3.14],0.443543779397979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,15929,37,0.93 [0.65-1.33],0.682076468913146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18641,50,1.35 [0.54-3.38],0.525751967791596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15575,36,0.77 [0.46-1.29],0.3231625127030083
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18581,50,1.03 [0.50-2.11],0.92957881871169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18631,49,1.25 [0.63-2.50],0.5249777943287917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,15991,37,1.21 [0.44-3.28],0.7130723930132388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15575,36,1.13 [0.66-1.94],0.6654653509520805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18412,50,0.85 [0.59-1.20],0.3520221230170303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,15983,38,1.28 [0.84-1.96],0.2529591567041847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18405,49,0.98 [0.58-1.66],0.9357367711189404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,15961,38,2.17 [0.73-6.46],0.1636979346540682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18411,49,1.21 [0.73-2.00],0.4574668801337612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18355,49,1.10 [0.70-1.73],0.6697187503477586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,17994,48,0.79 [0.50-1.26],0.3272904852526295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18444,49,1.25 [0.73-2.14],0.4058923844668584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,15982,38,1.00 [0.57-1.73],0.988862988127133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18352,49,0.47 [0.31-0.72],0.0005056581717893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18412,50,0.87 [0.49-1.56],0.647574777399113
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18546,48,1.01 [0.59-1.73],0.9706922091917356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18105,49,0.80 [0.49-1.30],0.3742002987737404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18411,49,0.93 [0.60-1.45],0.7553826926153415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18405,49,0.63 [0.45-0.90],0.01174928764358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,17994,48,0.60 [0.36-1.01],0.0555730775572111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15460,36,1.27 [0.86-1.89],0.2293635726794273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15460,36,0.65 [0.33-1.26],0.2000313290135361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,17994,48,1.16 [0.85-1.59],0.3564613998466702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,17994,48,0.91 [0.52-1.61],0.756269609061408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18478,49,1.40 [0.61-3.23],0.4258714842956306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15642,37,1.51 [0.55-4.17],0.4291297559782212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",15961,38,1.11 [0.76-1.63],0.5783724341901118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15505,38,1.16 [0.68-1.97],0.5797478002048633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15505,38,1.15 [0.61-2.18],0.658480467966349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18471,49,1.23 [0.89-1.69],0.2103450280314189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18405,49,0.86 [0.59-1.26],0.4523579772858935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15505,38,0.84 [0.38-1.87],0.6677868383138348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18561,48,0.94 [0.75-1.17],0.55537589900748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18554,48,1.01 [0.61-1.67],0.9637357175450736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15505,38,1.63 [0.87-3.04],0.1259083346724797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18105,49,1.17 [0.55-2.46],0.6883592668628863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15505,38,0.88 [0.37-2.08],0.7632365894043043
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15431,38,1.18 [0.84-1.64],0.3404304009790293
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15404,38,1.43 [0.65-3.13],0.3732921734232275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18453,48,1.89 [0.99-3.58],0.0519726801257926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,15991,37,0.77 [0.41-1.45],0.4197434105576056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,15954,38,0.95 [0.41-2.20],0.9050647315350384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18453,48,1.08 [0.34-3.42],0.9006985705702187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15631,36,1.11 [0.59-2.07],0.7487313215732037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16003,38,0.98 [0.60-1.59],0.92807549936849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18017,48,1.18 [0.83-1.68],0.3504167325420579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15499,37,0.90 [0.58-1.39],0.6308905351199973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15460,36,0.44 [0.20-0.98],0.0443523867784241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18017,48,1.05 [0.74-1.51],0.7781182347415179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18379,49,0.95 [0.68-1.33],0.7777886426346144
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,15961,38,0.99 [0.73-1.35],0.9549274077926994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18480,49,0.92 [0.73-1.16],0.4796685476496353
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18261,48,1.31 [0.71-2.39],0.384456092257913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18261,48,1.12 [0.85-1.47],0.4324043023106121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,17989,48,0.96 [0.55-1.69],0.8901465327014462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,15929,37,1.00 [0.59-1.70],0.9998512011442224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,17994,48,1.00 [0.80-1.27],0.9757863427472648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18261,48,1.21 [0.50-2.94],0.6766813224174634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18284,48,2.98 [1.12-7.91],0.028196119602368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,17994,48,0.59 [0.24-1.48],0.2617046090117952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18631,49,0.87 [0.42-1.80],0.7053338393493471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18453,48,0.97 [0.46-2.05],0.9401517509314484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18017,48,1.24 [0.93-1.65],0.1414169624485849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,17994,48,1.00 [0.48-2.08],0.9990959533399032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16006,37,1.32 [0.42-4.19],0.637919430252079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,15954,38,1.13 [0.59-2.18],0.7173567309824507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,15926,38,1.51 [0.76-3.01],0.2441962659486451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15505,38,1.01 [0.76-1.35],0.936237661298256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18371,48,1.11 [0.46-2.66],0.8206730182570633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18575,49,1.52 [0.64-3.60],0.3391014168825105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18396,47,1.03 [0.91-1.17],0.6399718484344465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15404,38,0.85 [0.35-2.05],0.7202617698141311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18017,48,1.20 [0.66-2.18],0.5499995476498546
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15505,38,1.16 [0.61-2.22],0.6451001384054591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18405,49,1.00 [0.75-1.35],0.992196574268757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,17994,48,0.88 [0.66-1.18],0.3999563331504605
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15460,36,0.93 [0.57-1.52],0.7788935637738891
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15575,36,1.03 [0.40-2.69],0.9480498905002654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18205,48,1.03 [0.35-2.98],0.9618992221417432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15538,37,1.28 [0.67-2.45],0.4547276590879153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18450,49,0.91 [0.53-1.56],0.7379107436574726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15538,37,0.67 [0.17-2.71],0.5775242955238673
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18350,48,0.83 [0.36-1.92],0.6583738314717897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,15916,38,1.00 [0.70-1.44],0.9981219096807746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18512,50,0.88 [0.67-1.17],0.3908738563232032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15631,36,1.13 [0.68-1.86],0.6448142309689362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18453,48,1.00 [0.46-2.20],0.9921421920621152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,17964,48,0.93 [0.47-1.83],0.8359236766726066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15680,38,0.90 [0.51-1.57],0.7069039908865855
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18575,49,0.96 [0.55-1.67],0.8846208854396591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18261,48,0.79 [0.50-1.25],0.3103717237710754
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18584,48,0.94 [0.66-1.33],0.7168827089314851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18105,49,0.92 [0.62-1.38],0.6927877835150333
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18373,49,0.94 [0.72-1.23],0.6591639332130808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15575,36,0.91 [0.50-1.65],0.748539905747412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15499,37,1.02 [0.49-2.14],0.9538919243878292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,15926,38,0.66 [0.31-1.40],0.2800743095333361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15707,38,1.17 [0.78-1.74],0.4485204365546075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15499,37,0.85 [0.48-1.50],0.5696222308036464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15431,38,0.75 [0.23-2.46],0.6292661504536958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15505,38,1.31 [0.76-2.24],0.3273546352197896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15707,38,0.93 [0.47-1.85],0.8337137965857367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15538,37,0.76 [0.40-1.45],0.4094361200469106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15431,38,0.53 [0.26-1.07],0.0755384566513735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18471,49,1.46 [1.00-2.12],0.0515874501947171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18321,48,0.55 [0.22-1.39],0.2044735353754804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18584,48,0.80 [0.31-2.07],0.6389595106830241
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18105,49,1.09 [0.61-1.94],0.7835629532023574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,15983,38,0.56 [0.19-1.70],0.309172482712023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18321,48,0.68 [0.20-2.29],0.5347733643465012
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15460,36,1.41 [0.67-2.96],0.3717185489693273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15289,36,0.76 [0.28-2.03],0.5811370112971377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,15961,38,1.18 [0.39-3.58],0.7703446067461233
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15707,38,1.01 [0.56-1.82],0.9712235341823748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18521,49,0.34 [0.12-0.93],0.0361081198059191
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15460,36,0.82 [0.38-1.74],0.6024134822724623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,15954,38,1.11 [0.90-1.37],0.3464403169697639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15431,38,0.71 [0.22-2.35],0.5761108856940484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15538,37,0.90 [0.59-1.38],0.6345827384563656
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15575,36,1.47 [0.91-2.35],0.1128396870955786
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,15926,38,1.24 [0.77-1.99],0.3678881689817247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18105,49,1.04 [0.68-1.58],0.8664907617215392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18017,48,0.76 [0.43-1.34],0.3453203195565426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15460,36,0.65 [0.26-1.62],0.3572157305615789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16006,37,0.39 [0.11-1.40],0.1499159527217435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,15954,38,0.97 [0.73-1.30],0.8565997585241617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,17994,48,0.98 [0.80-1.20],0.8413555239504692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15256,35,1.10 [0.58-2.08],0.7695669787974726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15460,36,1.40 [0.82-2.39],0.2141067820702532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18321,48,1.03 [0.49-2.17],0.9332820895411544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18641,50,0.86 [0.47-1.57],0.6243226023947908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18412,50,0.76 [0.37-1.56],0.4622939007652791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18017,48,0.97 [0.49-1.93],0.9410676463902944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,15983,38,0.82 [0.43-1.56],0.5449228647838444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,17964,48,0.92 [0.53-1.61],0.770648320125946
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,17994,48,1.00 [0.66-1.50],0.9831136047517482
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,17994,48,0.91 [0.71-1.16],0.4453076866590879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18561,48,0.59 [0.22-1.53],0.2741302276146545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18321,48,0.95 [0.27-3.28],0.9311581516274088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18205,48,1.12 [0.45-2.82],0.8061215531891972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15493,37,1.03 [0.62-1.72],0.9120340308371886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18017,48,1.14 [0.82-1.58],0.4527941497960107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,15983,38,1.02 [0.66-1.59],0.9282865379465106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,15956,38,1.19 [0.63-2.25],0.5852332762682178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18119,49,0.86 [0.40-1.84],0.70379887479088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18379,48,0.69 [0.39-1.21],0.1933847892724677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18261,48,2.44 [1.00-5.94],0.0498123598748692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18392,50,1.10 [0.96-1.25],0.1812971980642486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,17994,48,1.08 [0.94-1.24],0.2781998243838428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15631,36,1.46 [0.46-4.64],0.5189746165638269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18017,48,0.67 [0.36-1.23],0.1977755668580411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18412,50,1.19 [0.88-1.61],0.2682219825665409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,15961,38,1.36 [0.67-2.77],0.3974876596842206
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,15961,38,0.89 [0.58-1.37],0.6014424383351556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15631,36,0.54 [0.17-1.71],0.2928789111261987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15431,38,1.55 [0.99-2.45],0.0565338929302485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15538,37,0.91 [0.50-1.67],0.7694826200704641
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,15954,38,2.44 [1.06-5.61],0.0351414057161273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,15929,37,0.99 [0.72-1.36],0.9570359196460392
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15505,38,0.93 [0.45-1.94],0.8556433233669853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15505,38,0.99 [0.71-1.37],0.9484986024172644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15431,38,0.72 [0.39-1.32],0.2866751508315379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17676,48,0.99 [0.39-2.53],0.98876099883086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15604,36,0.58 [0.26-1.29],0.1839641282637937
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18261,48,0.54 [0.29-1.02],0.0588962918194647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15505,38,1.44 [0.67-3.09],0.3563734345318671
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18087,48,1.54 [1.00-2.37],0.0496454426885849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18358,49,1.34 [0.64-2.81],0.4336334981486086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15499,37,1.39 [0.69-2.80],0.3581094978448587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18292,50,1.58 [1.05-2.38],0.029049411823077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15631,36,0.82 [0.56-1.20],0.3014288076906289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18017,48,1.38 [0.95-2.00],0.093516558083315
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,15926,38,1.50 [1.04-2.15],0.0299015575656193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15604,36,1.18 [0.52-2.64],0.6948699983371958
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,15983,38,1.10 [0.71-1.70],0.6629574526056925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18631,49,1.26 [0.73-2.18],0.396463613062418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15631,36,1.02 [0.63-1.67],0.9267354277182114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,15961,38,0.66 [0.41-1.07],0.0917203873414002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,17994,48,0.88 [0.59-1.32],0.5515645798866687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15575,36,1.20 [0.71-2.03],0.4955221825524428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18411,49,1.17 [0.73-1.86],0.5116209269705534
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15538,37,1.37 [0.68-2.78],0.3773782201234913
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15631,36,0.44 [0.18-1.12],0.0847245875912834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,15961,38,1.05 [0.70-1.55],0.8218334579940452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18575,49,1.84 [0.64-5.30],0.2555327591329317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18405,49,1.00 [0.78-1.28],0.9887524404962822
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,15929,37,0.85 [0.43-1.69],0.6486631899751312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",15991,37,0.86 [0.40-1.85],0.7078665573708576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18360,49,1.03 [0.48-2.22],0.9400833362321942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15460,36,0.74 [0.46-1.19],0.2103619036770196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17856,48,0.82 [0.58-1.15],0.240968174709221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15631,36,0.50 [0.22-1.14],0.1010958645424145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18373,49,1.01 [0.76-1.35],0.94009180218022
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18321,48,1.11 [0.92-1.34],0.2642678788063176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18584,48,0.62 [0.26-1.48],0.2833746757816338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18261,48,0.87 [0.55-1.38],0.5577404729440335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,15926,38,0.83 [0.45-1.54],0.5581200697598929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,15929,37,0.77 [0.33-1.80],0.5522634583407999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16003,38,1.09 [0.57-2.08],0.8002420280142768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,15929,37,0.80 [0.57-1.14],0.2242255594180316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18017,48,0.72 [0.26-1.96],0.5165796812418539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,17925,50,1.16 [0.48-2.78],0.7446988601170899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15499,37,1.09 [0.65-1.81],0.746137675248034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,15961,38,1.23 [0.54-2.80],0.6186714689603628
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,15929,37,0.72 [0.44-1.17],0.186316128790505
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18087,48,0.86 [0.58-1.29],0.4669765140582371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,15926,38,1.17 [0.72-1.91],0.5236867613108978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18412,50,1.04 [0.86-1.26],0.6969611291789093
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,15983,38,0.99 [0.60-1.63],0.9652140264684532
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",15961,38,1.51 [0.88-2.58],0.1349415967608124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15499,37,0.93 [0.50-1.73],0.8152476702699887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18087,48,1.01 [0.61-1.67],0.9687330684324782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18311,48,2.18 [0.80-5.96],0.1280517155999173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15538,37,0.88 [0.49-1.57],0.6634160515216633
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18321,48,0.68 [0.42-1.10],0.1180035739670165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15344,38,0.86 [0.58-1.28],0.4576051104375236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,17994,48,0.91 [0.65-1.29],0.6039233463472427
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,15935,38,1.20 [0.23-6.40],0.8304701170635634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",15919,38,1.13 [0.28-4.57],0.8625035036192914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18383,50,0.88 [0.65-1.20],0.4350992232339773
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,17994,48,0.81 [0.56-1.16],0.2529312156812131
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15460,36,1.06 [0.70-1.61],0.7778630257015897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,17904,48,0.97 [0.67-1.42],0.8945909220207177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,15954,38,1.01 [0.89-1.16],0.8312859212187741
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15707,38,1.27 [0.92-1.76],0.1380816318879135
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15575,36,0.94 [0.63-1.40],0.7710300618769654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18310,49,1.84 [0.93-3.63],0.0790399386141849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15707,38,0.96 [0.64-1.44],0.8378409362893497
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15460,36,1.12 [0.54-2.35],0.7618134754174862
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18489,50,0.95 [0.63-1.43],0.8204987786392919
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18087,48,1.04 [0.78-1.37],0.8035089910013533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18631,49,0.64 [0.29-1.39],0.2586893801771736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18405,49,0.79 [0.52-1.21],0.2810655990456306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18087,48,0.98 [0.70-1.38],0.9205576304965396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15431,38,0.65 [0.28-1.55],0.3341077037529865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15460,36,0.71 [0.36-1.42],0.330697257900914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18535,48,1.25 [0.88-1.78],0.2194283446358231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18584,48,1.02 [0.82-1.25],0.8814328627792367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18411,49,1.06 [0.76-1.48],0.7216349027665099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18558,48,1.02 [0.68-1.53],0.927513068242614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18411,49,1.20 [0.59-2.44],0.6131192916704459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18535,48,0.75 [0.53-1.07],0.1140910180348634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18584,48,1.41 [0.98-2.03],0.0676181255571635
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,15983,38,1.21 [0.92-1.60],0.1736588018869566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15460,36,1.04 [0.59-1.83],0.8801799138462038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18631,49,1.20 [0.75-1.90],0.4453281199029368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15505,38,1.25 [0.84-1.87],0.2776129805147121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15499,37,1.10 [0.72-1.68],0.6646253070295369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,15929,37,1.61 [0.83-3.11],0.1601358307678879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18549,48,0.82 [0.62-1.09],0.173376970791706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,15954,38,1.46 [0.97-2.19],0.0705943827417186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18087,48,1.05 [0.65-1.69],0.8383329393588419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15631,36,0.86 [0.27-2.81],0.8089572616345846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,15954,38,1.19 [0.59-2.42],0.6299912523095943
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,15983,38,0.72 [0.32-1.63],0.4375969309803601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18405,49,0.93 [0.68-1.28],0.664106417951533
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18631,49,0.96 [0.46-1.99],0.9087308271892988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,15863,38,0.63 [0.21-1.91],0.416601120149408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,17994,48,0.95 [0.67-1.33],0.7617497308497991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,15954,38,1.01 [0.67-1.52],0.953164667530486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15505,38,1.04 [0.64-1.69],0.8601804935247399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15460,36,1.07 [0.44-2.63],0.8793415242137449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,15919,38,1.09 [0.57-2.05],0.8018420373607564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,15961,38,1.48 [0.86-2.53],0.1528953207825901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18087,48,1.42 [0.56-3.57],0.4592421122728189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",15961,38,0.87 [0.34-2.22],0.7685638007096522
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18343,49,0.81 [0.40-1.65],0.5591118507952508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18405,49,1.08 [0.46-2.58],0.8542971398012733
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18584,48,1.87 [0.99-3.54],0.054639997308023
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15601,36,0.76 [0.44-1.30],0.3131759721091199
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15538,37,0.90 [0.46-1.75],0.751155990405137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15460,36,0.93 [0.43-2.01],0.862977741579714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15393,38,0.70 [0.32-1.54],0.3789199221176423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18215,50,1.39 [0.85-2.28],0.1936809237904077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18017,48,0.94 [0.54-1.66],0.835392526747196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15575,36,1.22 [0.87-1.71],0.2599431051737212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18177,48,1.15 [0.68-1.97],0.6009834746788747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18022,48,1.13 [0.82-1.57],0.4461619173486872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,15961,38,1.23 [0.71-2.13],0.4699982527121737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18631,49,1.00 [0.71-1.40],0.9857737083294136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,17994,48,0.79 [0.39-1.58],0.5026432815698426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,15797,37,1.00 [0.71-1.39],0.9793307820806236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15678,38,1.01 [0.73-1.38],0.9718536114929304
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15538,37,1.08 [0.41-2.85],0.8771859716642668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,15938,37,0.98 [0.36-2.69],0.9674614282964588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15538,37,1.01 [0.71-1.44],0.946079964605133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18321,48,0.79 [0.40-1.58],0.5077552146848386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18584,48,1.52 [0.87-2.67],0.1400704418235481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15505,38,1.69 [0.78-3.67],0.1813036703092621
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15538,37,0.77 [0.54-1.09],0.134745710653571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18405,49,0.65 [0.34-1.22],0.1784357203041978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,15954,38,1.06 [0.65-1.74],0.807669532620181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15460,36,1.83 [1.24-2.69],0.0021874447229548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15538,37,1.08 [0.56-2.07],0.8263345184245805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,17934,48,0.97 [0.64-1.46],0.88309084164255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18437,49,1.02 [0.71-1.46],0.9073724597134184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,15926,38,1.19 [0.52-2.70],0.6797136559479695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18123,50,0.94 [0.66-1.34],0.739120886758876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18584,48,1.01 [0.54-1.90],0.9730205958614412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18300,49,1.74 [0.73-4.15],0.2089660280513753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15499,37,1.14 [0.77-1.68],0.5252315216142606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15499,37,1.08 [0.54-2.13],0.8329593050922581
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18453,48,0.95 [0.62-1.45],0.8044533323670716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18338,49,0.34 [0.11-1.04],0.0591593018358771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18641,50,2.07 [0.71-6.06],0.1847497477609563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18105,49,0.97 [0.70-1.34],0.833412483928602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18355,49,1.12 [0.47-2.70],0.7967649542318092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18641,50,0.65 [0.31-1.37],0.2578923617719586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18641,50,0.50 [0.19-1.33],0.1638515651968667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18405,49,1.08 [0.67-1.76],0.744924925194031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18412,50,0.79 [0.46-1.34],0.3837270436965343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18321,48,1.85 [0.48-7.18],0.3756116290216778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15707,38,1.12 [0.59-2.15],0.7285414916713725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18017,48,1.13 [0.69-1.87],0.6208542811588228
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15538,37,0.82 [0.48-1.39],0.4624428692058832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18631,49,1.99 [0.12-31.84],0.6279720021212404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18584,48,0.82 [0.48-1.41],0.47469096936579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15566,36,0.66 [0.28-1.54],0.3360120457048259
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15707,38,1.23 [0.70-2.15],0.4671775443824216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15707,38,2.01 [1.10-3.69],0.0230174128665878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,15929,37,0.69 [0.19-2.54],0.5802148105228858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18105,49,1.00 [0.80-1.25],0.9972656760857204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18471,49,1.22 [0.38-3.94],0.7408144554420412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18261,48,0.91 [0.55-1.50],0.7134135941312438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18017,48,1.13 [0.64-1.99],0.66992341051519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15499,37,1.20 [0.78-1.84],0.4055294211072384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18405,49,0.95 [0.46-1.99],0.9015077249160468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15460,36,0.64 [0.20-1.99],0.4379900660503816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15575,36,0.69 [0.31-1.55],0.3682996514731623
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,15961,38,1.35 [0.82-2.22],0.2355761125281239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15499,37,1.23 [0.72-2.09],0.4437412113398273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,15991,37,0.36 [0.16-0.79],0.0113518391571009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18321,48,0.98 [0.30-3.24],0.9743861250561868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15460,36,1.28 [0.71-2.32],0.4057505594104506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18411,49,0.90 [0.31-2.59],0.8473269728072423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18616,50,0.98 [0.80-1.20],0.8672787494053388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18610,49,1.14 [0.74-1.73],0.5547287453050354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18500,49,1.20 [0.54-2.70],0.6522519767624637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18187,48,1.06 [0.59-1.89],0.8474992798246066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18352,49,1.61 [0.77-3.39],0.2056247554514039
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18641,50,0.73 [0.31-1.75],0.483796585785357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18412,50,1.32 [0.64-2.71],0.4490526022330182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15505,38,1.20 [0.86-1.67],0.2937113909164565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15460,36,1.23 [0.75-2.01],0.4134816636636863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,15983,36,0.56 [0.11-2.85],0.4823984119846346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15431,38,1.14 [0.86-1.51],0.3529976799790177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15538,37,0.96 [0.43-2.18],0.9303132231216252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18321,48,0.69 [0.30-1.55],0.3654357480032669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18412,50,1.24 [0.56-2.72],0.5986613590464152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,15983,38,1.10 [0.77-1.58],0.5874800680147205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18405,49,1.02 [0.77-1.35],0.8879222959480881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,17994,48,0.91 [0.66-1.26],0.5732785571783381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18105,49,1.03 [0.75-1.42],0.8590397692935017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18105,49,1.36 [1.02-1.82],0.0371366664962477
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18471,49,1.25 [0.54-2.89],0.603091535390712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18105,49,0.82 [0.51-1.30],0.3936585677915675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18321,48,1.28 [0.93-1.77],0.1280810958279076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18631,49,1.56 [0.99-2.47],0.0557832129489761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18105,49,1.52 [0.78-2.94],0.216978507939745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15505,38,0.93 [0.43-2.04],0.8635116565937446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18105,49,0.82 [0.44-1.54],0.5435407081576622
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18167,46,1.56 [0.52-4.70],0.4254823496943035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15499,37,1.52 [0.51-4.54],0.4541978822859617
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18405,49,1.40 [0.68-2.91],0.3613708715824711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18105,49,1.15 [0.55-2.40],0.7057312308428061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18631,49,1.17 [0.67-2.05],0.5894242853879648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18065,49,1.01 [0.56-1.84],0.9636030713044028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18105,49,1.39 [1.05-1.85],0.0235095141983316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18105,49,1.61 [1.12-2.32],0.0110041107951612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18105,49,1.39 [1.10-1.76],0.0062641820756173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18411,49,0.94 [0.53-1.68],0.8423273365993222
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18181,48,0.93 [0.57-1.51],0.7742625904192606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18317,48,1.66 [0.97-2.83],0.0637925195727341
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18500,49,1.36 [0.61-3.03],0.4508050728653391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18631,49,0.80 [0.37-1.75],0.578182190683731
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18147,47,0.94 [0.80-1.11],0.4412182110810517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,17950,49,0.85 [0.59-1.24],0.4021763891109464
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18105,49,0.92 [0.59-1.45],0.7185150461690978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18020,49,1.06 [0.68-1.65],0.7829166023564349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18379,48,0.55 [0.18-1.68],0.2912268287053648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18351,48,0.52 [0.15-1.84],0.3097946299949399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18411,49,2.04 [1.22-3.41],0.0062696422815799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18581,50,0.80 [0.48-1.35],0.4052459252881873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18105,49,0.91 [0.46-1.80],0.7778269699145455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18350,49,0.92 [0.56-1.51],0.7322281476055933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18105,49,1.12 [0.50-2.49],0.7831893678575553
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18105,49,1.18 [0.76-1.84],0.4523606315028885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18105,49,0.95 [0.53-1.73],0.8722084608649423
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15505,38,1.21 [0.59-2.47],0.5977776529304653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15505,38,1.61 [1.20-2.15],0.0012940452447779
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,15926,38,0.97 [0.62-1.53],0.8985574409422017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18105,49,0.65 [0.32-1.33],0.2426220681563271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18105,49,1.19 [0.75-1.88],0.46535910952127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15373,38,0.35 [0.15-0.83],0.017358759160543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18295,49,1.19 [0.64-2.21],0.5897163624915763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18105,49,1.42 [0.80-2.53],0.2367518281356214
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,15926,38,1.34 [0.66-2.69],0.4154935567052847
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15431,38,0.78 [0.52-1.16],0.2164270021700595
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15505,38,1.15 [0.71-1.89],0.5667468762832593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15449,38,1.46 [0.64-3.30],0.3697723031485034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18405,49,1.00 [0.56-1.82],0.9874492712013554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18105,49,0.87 [0.46-1.65],0.6638587618725447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,17987,48,0.75 [0.37-1.49],0.4095641568006235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15505,38,0.87 [0.47-1.61],0.6555848454033544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15460,38,1.09 [0.70-1.68],0.7053523225809823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18105,49,1.45 [0.66-3.16],0.353608188049978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18105,49,1.00 [0.76-1.32],0.984839746229114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18405,49,1.41 [0.72-2.74],0.3169772645330795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18105,49,0.99 [0.82-1.19],0.892626207660231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18405,49,0.78 [0.49-1.24],0.2947897708062432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18321,48,1.21 [0.90-1.62],0.2140490266892118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18330,49,1.02 [0.49-2.14],0.949184360132584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18412,50,0.37 [0.09-1.63],0.189799836354507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18405,49,1.08 [0.73-1.60],0.6984882781020574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18411,49,0.96 [0.60-1.55],0.8679665690441952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15707,38,1.67 [1.24-2.25],0.0006389515056783
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,17986,48,1.01 [0.65-1.57],0.980960479574124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,15926,38,0.92 [0.45-1.89],0.8160043696530128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18261,48,1.05 [0.69-1.60],0.8253286002211647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,15954,38,1.16 [0.66-2.03],0.6145852367498867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15499,37,1.00 [0.36-2.75],0.9982964890751372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,17989,48,1.08 [0.64-1.81],0.7797184613518725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15631,36,0.79 [0.42-1.50],0.477312921467403
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18411,49,1.05 [0.55-2.00],0.8762618716427996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18321,48,0.90 [0.55-1.47],0.6828509450939682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15538,37,0.99 [0.56-1.72],0.9589180434790776
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",15961,38,0.94 [0.43-2.07],0.8839630974902077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18321,48,1.01 [0.78-1.31],0.9460180937559498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,15954,38,0.96 [0.68-1.35],0.8177654999083607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,15926,38,1.14 [0.63-2.03],0.6676269629998873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,15929,37,0.79 [0.56-1.11],0.176107754132752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15505,38,0.63 [0.10-4.20],0.6351689068954861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18227,48,1.11 [0.83-1.48],0.469693908127608
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18321,48,0.83 [0.51-1.36],0.4580722285607347
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18087,48,1.17 [0.90-1.53],0.2426586784962335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18105,49,1.04 [0.72-1.51],0.8169672776691221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18405,49,1.08 [0.84-1.38],0.561415186385602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17742,47,0.52 [0.26-1.03],0.0605046354184674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18405,49,0.76 [0.40-1.46],0.4087968532435824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,15991,37,1.29 [0.71-2.36],0.3985386638222393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,15803,37,0.96 [0.69-1.32],0.7836562471647186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18405,49,0.98 [0.46-2.07],0.951755529098694
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15631,36,1.19 [0.47-3.02],0.7105136126760424
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18411,49,0.62 [0.22-1.77],0.3697179105441478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18405,49,1.01 [0.62-1.64],0.9779140266260344
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15505,38,0.85 [0.42-1.71],0.6525657661780613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18411,49,1.49 [0.69-3.22],0.3127733136974444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18584,48,0.79 [0.17-3.64],0.767506147211925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15707,38,0.92 [0.49-1.74],0.8032653667288552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18415,49,0.88 [0.26-3.02],0.8442341554824218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,17994,48,0.86 [0.45-1.64],0.6463129077858571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18087,48,1.03 [0.81-1.29],0.8252642274838418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18321,48,1.10 [0.45-2.72],0.8354897908953456
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18453,48,0.72 [0.36-1.45],0.3582613212198071
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18105,49,1.22 [0.54-2.77],0.6328475631204966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18584,48,0.64 [0.35-1.15],0.1366567600058991
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,15991,37,1.19 [0.55-2.59],0.653241046095713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16006,37,3.06 [0.95-9.84],0.0610642667280468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18500,49,1.29 [0.66-2.51],0.4572325018129397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16006,37,1.80 [0.55-5.97],0.3338361031651389
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,15926,38,1.38 [0.80-2.38],0.244336118543616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18405,49,1.02 [0.68-1.53],0.9201014613693318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15460,36,1.12 [0.70-1.80],0.6422390661828737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15538,37,1.14 [0.74-1.74],0.5593150971716458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15499,37,1.40 [0.80-2.44],0.2371858942623081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18017,48,0.87 [0.51-1.47],0.5949114100971162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15431,38,0.83 [0.39-1.76],0.6288932852262578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18575,49,1.29 [0.51-3.25],0.5878230381807357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15631,36,0.60 [0.29-1.23],0.1647134555713518
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18105,49,0.91 [0.60-1.38],0.6732322230630369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15431,38,1.09 [0.65-1.83],0.7375186677639398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,15929,37,0.95 [0.66-1.36],0.7709724837107428
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18105,49,1.05 [0.64-1.73],0.8343759489099168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18321,48,0.83 [0.49-1.42],0.5039081313352369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,15929,37,1.02 [0.76-1.38],0.8863856730798583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15499,37,1.02 [0.57-1.83],0.9414598441690922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15575,36,0.89 [0.55-1.45],0.6413204387898429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18017,48,0.88 [0.51-1.54],0.6591513942227405
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15640,38,1.59 [0.98-2.59],0.061222095100869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15505,38,1.03 [0.73-1.44],0.8696825201522701
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18453,48,1.30 [0.47-3.56],0.6123990800473181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18017,48,1.60 [0.79-3.21],0.1900247256969625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15431,38,0.65 [0.33-1.27],0.2030234277272821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15538,37,0.98 [0.59-1.63],0.9341501291906112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,15954,38,1.83 [0.85-3.92],0.120474198754267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15707,38,1.01 [0.65-1.57],0.9595761568291212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15707,38,1.30 [0.46-3.71],0.6193133228200826
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,15926,38,1.72 [1.30-2.29],0.0001648408811336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15460,36,1.22 [0.54-2.74],0.6281997487597759
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15499,37,1.26 [0.90-1.77],0.1853540357743726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15460,36,1.30 [0.98-1.73],0.0645366093712002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18321,48,1.02 [0.75-1.39],0.881984638339051
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,15926,38,0.76 [0.54-1.09],0.136211518036713
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,17994,48,0.69 [0.49-0.97],0.0342893006425446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,15929,37,0.94 [0.78-1.14],0.549272145930785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,17994,48,0.98 [0.80-1.21],0.8800024539006865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15431,38,1.01 [0.70-1.45],0.9503583409936374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15499,37,1.36 [0.94-1.97],0.1070597191530789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18017,48,0.70 [0.36-1.35],0.2846787776378386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18478,49,0.83 [0.35-1.96],0.6632545338889164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18412,50,2.07 [1.04-4.10],0.0376260571984736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18017,48,1.02 [0.73-1.45],0.8894715643937984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15499,37,1.39 [0.74-2.61],0.3045793194598235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,15961,38,1.23 [0.72-2.10],0.4446419658099989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18236,47,1.04 [0.86-1.27],0.6678397247701067
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18400,48,1.03 [0.55-1.94],0.921590710768472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18269,48,1.37 [0.68-2.77],0.3804047945707939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,17994,48,1.16 [0.95-1.42],0.1546797644202892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,17984,48,1.05 [0.59-1.87],0.8651478118964506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18584,48,1.06 [0.61-1.83],0.843439333030061
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,15895,38,1.45 [0.80-2.63],0.2222707032146678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,15991,37,1.27 [0.97-1.68],0.0857466790401289
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18584,48,0.97 [0.64-1.47],0.8929241813539316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18416,48,1.89 [0.83-4.29],0.1287667425179599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15251,36,0.83 [0.35-1.95],0.6710775368429005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,17786,46,1.04 [0.50-2.17],0.9146225300844706
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15690,36,2.06 [0.55-7.72],0.2827832076925385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18631,49,1.11 [0.57-2.15],0.7610874285821247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15499,37,0.77 [0.40-1.47],0.4228737302971935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18631,49,0.83 [0.49-1.43],0.5081937076746861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15505,38,0.74 [0.31-1.74],0.4858074686076018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,15954,38,1.40 [0.76-2.58],0.2870714575677145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17466,47,0.76 [0.29-1.99],0.5775468508138576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15460,36,0.57 [0.23-1.41],0.2240271049081346
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18321,48,1.05 [0.77-1.42],0.7683903802214965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18374,49,1.03 [0.71-1.50],0.8740954753966853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18017,48,1.70 [1.13-2.57],0.0111864386032808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15460,36,0.78 [0.30-2.07],0.6225095125516433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15499,37,1.12 [0.81-1.54],0.485198681766121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18381,50,1.29 [0.84-1.98],0.2390257278849404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18631,49,0.88 [0.50-1.56],0.6592074011266988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18453,48,0.81 [0.34-1.93],0.6397010023452863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,15983,38,0.98 [0.69-1.38],0.8874778678756089
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,15892,38,0.57 [0.23-1.44],0.2363202713191322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18412,50,1.09 [0.75-1.60],0.6429494869767127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18321,48,1.26 [0.68-2.34],0.463578256757391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18380,48,0.73 [0.35-1.53],0.4109687435351772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18261,48,1.33 [1.02-1.73],0.0334908183602632
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15460,36,0.70 [0.31-1.56],0.3838710284929573
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18471,49,0.73 [0.34-1.56],0.4187577598891123
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15538,37,0.90 [0.32-2.50],0.8326293410357797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15560,36,0.44 [0.10-1.82],0.256347970865127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,17855,48,1.94 [0.55-6.88],0.3044383164765292
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18598,49,0.93 [0.58-1.51],0.7800747339464639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,15926,38,0.61 [0.26-1.46],0.2671711581794916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18105,49,1.16 [0.70-1.92],0.5708348640672745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,15926,38,0.94 [0.56-1.58],0.8092326967653851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18631,49,1.00 [0.72-1.40],0.9894036479225627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18321,48,0.97 [0.79-1.19],0.7877942651906278
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15505,38,0.92 [0.64-1.33],0.6633712555532858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18233,48,0.99 [0.47-2.09],0.9800046162826864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18500,49,0.97 [0.63-1.49],0.8908160177730411
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18575,49,1.02 [0.71-1.46],0.9113132748928312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16003,38,1.81 [0.43-7.69],0.4209372508326306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,15961,38,1.34 [0.90-1.99],0.1516878977966926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,17887,49,1.37 [0.74-2.52],0.316214028130229
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,15991,37,0.65 [0.32-1.32],0.2316101107046173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18459,50,0.95 [0.58-1.55],0.8291497495832523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,15961,38,0.98 [0.72-1.34],0.8948921348140177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,15983,38,1.46 [0.95-2.26],0.0837308121697297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18561,48,0.99 [0.61-1.63],0.9824394664516104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15091,35,1.06 [0.66-1.71],0.8132770305352401
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15499,37,1.39 [1.02-1.89],0.0399412744640777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,15961,38,1.16 [0.49-2.79],0.7333339448266467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18412,50,0.94 [0.66-1.35],0.7502429504736878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18412,50,1.05 [0.47-2.32],0.9064518557161164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,15961,38,1.35 [0.81-2.25],0.2461563002510888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18412,50,1.09 [0.53-2.23],0.8176579648424005
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18465,48,1.12 [0.47-2.64],0.8030098901227997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16006,37,1.74 [0.78-3.86],0.1746239771337614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18380,48,1.32 [0.86-2.04],0.2026673318141646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18381,48,0.85 [0.46-1.58],0.607418694936106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18575,49,1.01 [0.66-1.53],0.9757846443861188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18392,49,1.14 [0.49-2.62],0.759957875671371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18471,49,0.87 [0.43-1.77],0.7051025777806852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,17994,48,0.83 [0.59-1.17],0.2806852531608879
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18408,49,1.26 [0.84-1.90],0.2654233543196523
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18017,48,1.04 [0.64-1.70],0.8691812801226422
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18405,49,0.43 [0.15-1.28],0.1289931604131008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18411,49,0.86 [0.43-1.74],0.6799163118985485
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,15991,37,0.88 [0.74-1.03],0.1174581489657856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15460,36,1.22 [0.69-2.14],0.4922863946342121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18392,50,0.76 [0.35-1.66],0.4956500093924296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,15983,38,0.82 [0.54-1.24],0.3538340037420873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18641,50,0.69 [0.27-1.72],0.4240404801294455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18550,49,0.64 [0.32-1.28],0.2082233577038679
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18105,49,1.42 [0.81-2.49],0.2216145567504619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18641,50,1.15 [0.80-1.67],0.4465841956091846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15538,37,1.36 [0.85-2.19],0.2001146606907889
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,15902,37,1.06 [0.66-1.70],0.8100703710119904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,15954,38,1.68 [0.65-4.35],0.2890921594421893
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,15961,38,1.30 [0.57-2.97],0.5328598281053805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15499,37,1.42 [0.96-2.09],0.0806842776835483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15538,37,0.91 [0.63-1.33],0.6353975984870412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15654,37,0.88 [0.75-1.05],0.162908193412828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18321,48,1.36 [0.94-1.96],0.1003549673101162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18412,50,1.07 [0.63-1.80],0.8137206396869276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,17769,47,1.29 [0.84-1.98],0.2362716422072226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15460,36,0.91 [0.55-1.49],0.7028668843855648
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15460,36,0.89 [0.54-1.44],0.6241416227060832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15575,36,1.04 [0.51-2.10],0.9234716654445516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16006,37,2.16 [0.69-6.81],0.1886511963538504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18535,48,0.80 [0.38-1.65],0.5389799532425219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15457,38,2.35 [1.14-4.81],0.0200805514862376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18321,48,0.56 [0.21-1.54],0.2648158867618431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18412,50,1.68 [0.87-3.22],0.1209244738391444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15575,36,1.41 [0.70-2.85],0.3400777596511157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15575,36,1.25 [0.92-1.70],0.1533912799774537
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18575,49,0.72 [0.41-1.26],0.2468118887857058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18321,48,1.12 [0.59-2.14],0.7302802229229812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,15929,37,1.43 [0.70-2.93],0.3274212177579455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15575,36,1.11 [0.58-2.11],0.7608797872765338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,15983,38,0.99 [0.52-1.90],0.9765995242790072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,15926,38,0.94 [0.49-1.80],0.856258081866309
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18105,49,1.22 [0.64-2.31],0.5465560661622133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15575,36,1.27 [0.69-2.34],0.4365942588533444
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,15961,38,0.92 [0.27-3.16],0.8932241046927136
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,17994,48,0.63 [0.35-1.13],0.121237023776377
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15707,38,1.16 [0.84-1.60],0.3736194660917065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18405,49,1.18 [0.63-2.18],0.6043602415051397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18405,49,0.75 [0.39-1.41],0.3656859153806409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18584,48,0.88 [0.56-1.37],0.5624408941269362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,15926,38,0.54 [0.19-1.56],0.2559846368417807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18641,50,0.96 [0.43-2.15],0.92471717765554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,17994,48,0.72 [0.42-1.24],0.2345218464344761
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18288,48,0.82 [0.33-2.03],0.6669199763169069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18105,49,0.95 [0.49-1.82],0.870764945722102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,15926,38,1.14 [0.58-2.26],0.6998742579585655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18177,47,1.14 [0.80-1.62],0.4705397176118062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18295,49,1.45 [0.80-2.65],0.2222307251313967
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18405,49,0.57 [0.31-1.04],0.0665957722857468
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18182,48,0.66 [0.27-1.61],0.3604912408514586
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18261,48,1.17 [0.59-2.32],0.6447956570856668
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,17994,48,1.01 [0.63-1.61],0.9797517492917274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18321,48,0.96 [0.71-1.29],0.7645052362537907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18017,48,0.93 [0.60-1.44],0.7382341525605833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18313,48,0.82 [0.38-1.78],0.6210741918973832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,17994,48,0.86 [0.50-1.50],0.6022809396688076
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15499,37,1.15 [0.90-1.47],0.2641117689460434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15575,36,1.06 [0.79-1.42],0.6948898664351563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16006,37,1.44 [0.29-7.05],0.6535039798253339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15431,38,1.39 [0.66-2.96],0.3893526005276072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15631,36,0.84 [0.53-1.33],0.4486863119174116
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15538,37,0.75 [0.28-1.97],0.5559897679612894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18204,48,1.30 [0.88-1.92],0.1880308040215931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,17994,48,0.58 [0.27-1.22],0.1491901542334458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15575,36,1.07 [0.55-2.08],0.8498683056694096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15707,38,1.14 [0.77-1.68],0.526589940855751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,17994,48,0.75 [0.42-1.33],0.3245012125121473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,15983,38,0.65 [0.26-1.61],0.3544489773663607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,15926,38,1.22 [0.72-2.07],0.4673964827012848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15538,37,0.61 [0.18-2.15],0.444806410166257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,15983,38,0.48 [0.29-0.80],0.0042806383865398
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15431,38,0.73 [0.39-1.39],0.3395025573143925
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18471,49,1.02 [0.82-1.25],0.8771317939147396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18453,48,0.98 [0.39-2.50],0.9743837557645548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15460,36,0.98 [0.61-1.57],0.9187733204831536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15499,37,1.33 [0.49-3.62],0.5718952398461394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15460,36,0.79 [0.41-1.52],0.4748044829308647
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,15954,38,0.91 [0.45-1.85],0.7985276345645238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,15929,37,1.00 [0.60-1.64],0.9865965213136576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18405,49,1.04 [0.80-1.34],0.7886425072190599
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,17994,48,1.04 [0.80-1.35],0.7627121589195307
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18233,48,1.02 [0.81-1.28],0.8614997098398236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15431,38,1.73 [1.14-2.63],0.0097599475025111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18405,49,0.86 [0.47-1.55],0.6095662650534543
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15707,38,0.78 [0.50-1.21],0.2630849793924554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15431,38,1.02 [0.83-1.25],0.8756078307813846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18017,48,0.73 [0.48-1.10],0.133052054751805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18412,50,0.30 [0.11-0.79],0.0145327584508419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15604,36,0.95 [0.65-1.39],0.7887279827953325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18233,48,2.93 [0.95-9.05],0.0620623159470121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18411,49,0.75 [0.31-1.80],0.517179029134644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18227,48,1.44 [0.69-3.00],0.3340761755231985
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,17994,48,0.87 [0.65-1.17],0.3711055926811281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18017,48,1.02 [0.80-1.31],0.8428433341451146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18641,50,1.25 [0.83-1.88],0.2913481842051124
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15792,37,1.11 [0.83-1.49],0.4761630526283258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18500,49,1.02 [0.46-2.25],0.956990059414197
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",15961,38,0.72 [0.31-1.68],0.4514570039137777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15505,38,0.76 [0.52-1.12],0.1598868652242948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18314,49,1.10 [0.62-1.93],0.7525367320092962
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,15929,37,0.41 [0.10-1.72],0.2208344730605789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18261,48,0.92 [0.64-1.33],0.6704846974648181
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",15921,38,1.13 [0.52-2.45],0.7620160492255803
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18389,47,0.78 [0.46-1.33],0.3588607937037895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15575,36,2.29 [0.98-5.37],0.05614415499869
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15538,37,0.91 [0.64-1.29],0.5973478264958951
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,17994,48,0.94 [0.67-1.32],0.7198916933711748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15460,36,1.58 [1.12-2.22],0.0095155389509366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18380,48,1.29 [0.68-2.43],0.4320091856659579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15460,36,0.99 [0.37-2.67],0.9855997754141652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18581,50,0.58 [0.15-2.17],0.4163918503859669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,15983,38,0.91 [0.32-2.61],0.8615877235623836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15631,36,1.44 [0.37-5.59],0.5978432800405168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,15929,37,0.68 [0.43-1.06],0.0875064364549407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18412,50,0.98 [0.79-1.22],0.8705066482827027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18380,48,0.84 [0.28-2.48],0.7537994543742478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18631,49,1.31 [0.47-3.64],0.6000737720872514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18411,49,1.00 [0.81-1.22],0.9636158574100868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18458,50,0.79 [0.21-2.90],0.7166242882070664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18017,48,0.88 [0.36-2.16],0.788311102512296
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18405,49,0.88 [0.65-1.20],0.4281483545726177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18561,48,1.12 [0.71-1.78],0.6182553635458639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18087,48,0.86 [0.47-1.55],0.6139068661126008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15575,36,0.79 [0.42-1.47],0.4581611859001385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15631,36,0.74 [0.27-2.01],0.5517650142551573
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18641,50,1.40 [0.75-2.62],0.2869130233375573
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18411,49,1.04 [0.59-1.83],0.8860719041487607
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18450,49,0.97 [0.73-1.29],0.8453092396040031
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18405,49,1.09 [0.88-1.35],0.4353207274747781
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18453,48,1.99 [1.11-3.56],0.0207767019727868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15575,36,0.99 [0.61-1.61],0.9633717674708804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18405,49,0.91 [0.79-1.06],0.2277833265721642
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18376,49,1.26 [0.86-1.85],0.2394187520557926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18105,49,0.98 [0.60-1.62],0.950635793117804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,15926,38,0.98 [0.74-1.31],0.9013396545037436
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,15954,38,1.03 [0.73-1.44],0.8760972076883947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18261,48,1.01 [0.78-1.32],0.920604731615926
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15505,38,1.25 [0.66-2.36],0.4996850115629102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15431,38,0.93 [0.57-1.52],0.7613358390952979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18405,49,1.21 [0.90-1.61],0.2049878969526642
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18321,48,1.01 [0.73-1.41],0.9396630993218106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,17800,49,0.90 [0.68-1.19],0.4708302806645001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18358,49,0.77 [0.49-1.21],0.2570329269135134
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18454,48,1.14 [0.72-1.80],0.5738726959319104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18017,48,0.38 [0.17-0.85],0.017801005101957
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,15983,38,1.40 [0.93-2.11],0.1117084878342618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18411,49,1.25 [0.76-2.06],0.3861479588690968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18061,46,0.84 [0.51-1.40],0.5056151318791777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18545,49,1.01 [0.71-1.43],0.9575980485740208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18391,49,1.29 [0.84-1.97],0.2407599041949329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15460,36,0.94 [0.49-1.80],0.8531233756912094
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15575,36,1.39 [0.93-2.07],0.1046049694605408
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15707,38,1.59 [1.02-2.47],0.0395537824984956
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18383,50,1.27 [1.04-1.54],0.0167172706897251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15631,36,0.64 [0.38-1.08],0.0928297163487001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18584,48,1.41 [0.66-3.00],0.3766163345157881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,15954,38,1.35 [0.50-3.61],0.5554226771335271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15707,38,1.52 [0.89-2.60],0.1287356982732863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15431,38,0.75 [0.30-1.88],0.5341224157906317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15431,38,0.82 [0.50-1.33],0.4197714936707385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18087,48,1.37 [1.01-1.87],0.0450387112382088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18321,48,0.95 [0.70-1.28],0.715319124810698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18450,49,0.87 [0.64-1.19],0.394093661430118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18411,49,1.66 [1.07-2.56],0.0227365509359592
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,15899,38,1.18 [0.61-2.26],0.6254278501916515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16003,38,0.77 [0.25-2.36],0.6503342965034246
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15575,36,1.76 [1.06-2.92],0.0276643960909457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15460,36,1.11 [0.52-2.39],0.7892071053905036
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",15961,38,0.71 [0.23-2.17],0.5497491955181439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18017,48,0.42 [0.15-1.20],0.1050536496653275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15393,38,0.67 [0.19-2.38],0.535656783561719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",15961,38,1.05 [0.69-1.60],0.8115872977881418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15505,38,0.65 [0.18-2.36],0.513368403832613
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18291,48,0.99 [0.64-1.52],0.967049011484396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15575,36,1.32 [0.61-2.86],0.4741980429495062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18392,48,1.57 [1.10-2.25],0.0135525341645653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18575,49,0.79 [0.48-1.29],0.3393088902456193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18453,48,1.04 [0.73-1.48],0.8266366184367616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15775,37,0.89 [0.61-1.30],0.5497334611230715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18087,48,0.89 [0.55-1.44],0.6355828328203439
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15505,38,1.07 [0.77-1.49],0.7052874514437579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",15954,38,0.66 [0.17-2.54],0.5421973303270526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15707,38,1.05 [0.80-1.38],0.7492622298424079
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",15929,37,1.13 [0.79-1.61],0.5038056843921339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18087,48,0.72 [0.30-1.73],0.4609354311611636
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15460,36,1.06 [0.66-1.68],0.8158610308073596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,15929,37,1.02 [0.77-1.36],0.8675386294971394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,15926,38,0.94 [0.69-1.28],0.6992177456115239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15707,38,0.98 [0.56-1.72],0.9366807664935244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18017,48,1.34 [0.83-2.16],0.226061171955245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18321,48,1.00 [0.88-1.15],0.9558827874271932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,15991,37,0.95 [0.67-1.33],0.76166171058263
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15431,38,0.51 [0.17-1.49],0.2186076932457133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18105,49,1.08 [0.79-1.48],0.6174828509766483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15631,36,0.94 [0.33-2.69],0.9094116385601434
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",15983,38,1.23 [0.85-1.77],0.2804854224031068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15538,37,1.27 [0.96-1.70],0.0994043204438143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,15961,38,1.05 [0.65-1.67],0.8496669669443255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,15983,38,1.00 [0.73-1.38],0.9774621818026784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15460,36,1.19 [0.63-2.26],0.5966773633783358
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15431,38,0.95 [0.45-2.01],0.8840312432549535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,15991,37,0.96 [0.73-1.26],0.7591702520047192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15460,36,1.56 [0.90-2.71],0.1152373081280017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15538,37,1.26 [0.85-1.87],0.2485759124992412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15538,37,1.44 [0.88-2.35],0.1433861860794396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15575,36,0.91 [0.62-1.33],0.6231115725828221
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15575,36,1.52 [1.02-2.29],0.041942430518923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,15961,38,1.61 [0.97-2.70],0.067397525263974
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18105,49,1.10 [0.76-1.60],0.6056719929752337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18411,49,0.60 [0.35-1.04],0.0680826898626834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15499,37,1.07 [0.58-2.00],0.8210070012499755
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15460,36,0.97 [0.53-1.75],0.9108647916586092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15631,36,1.05 [0.75-1.47],0.7596844203652727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18432,49,0.73 [0.44-1.22],0.2254588709353087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,17994,48,0.76 [0.44-1.33],0.3333325227289219
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15460,36,0.89 [0.47-1.68],0.7136859111273173
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15575,36,0.97 [0.75-1.26],0.8249187352474829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18181,48,0.51 [0.32-0.82],0.0057315543532066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,15926,38,0.92 [0.52-1.62],0.7685616015436552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18412,50,1.36 [0.95-1.95],0.0916625130667695
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15478,38,1.00 [0.58-1.73],0.995469895932682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15510,37,1.07 [0.61-1.88],0.8007259478305397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15631,36,0.53 [0.12-2.24],0.3851980211728196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,17994,48,1.17 [0.77-1.76],0.4574635557980978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,15891,37,0.74 [0.37-1.49],0.4062086689126112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,15954,38,1.68 [0.76-3.73],0.2032272311244378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",15961,38,1.30 [0.67-2.54],0.4427066334778042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18453,48,1.41 [0.55-3.57],0.4724350765789391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18105,49,1.10 [0.71-1.71],0.662130379736536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18500,49,1.56 [0.74-3.31],0.2432473070931343
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18411,49,0.46 [0.18-1.19],0.1095466854353243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18575,49,1.78 [0.90-3.52],0.0997466056378247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18366,49,1.16 [0.88-1.51],0.2910503601259414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18471,49,0.99 [0.78-1.25],0.9027726938505016
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18105,49,1.04 [0.65-1.66],0.8704747926139471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18380,49,1.02 [0.52-2.01],0.9482480179487236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,15929,37,0.88 [0.36-2.13],0.7686655656832029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18584,48,0.99 [0.40-2.46],0.9871711716124664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18017,48,0.91 [0.59-1.42],0.6807177129507491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,15926,38,1.34 [0.92-1.95],0.1245133150985099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15476,38,0.92 [0.38-2.23],0.8561976695100488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,15929,37,0.93 [0.65-1.33],0.6897898307808601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",17994,48,0.92 [0.65-1.32],0.6598809935031784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15460,36,1.34 [0.68-2.63],0.3994765676166306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15460,36,0.78 [0.45-1.35],0.3721149600405058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15505,38,1.25 [0.55-2.88],0.5922865335024291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18392,50,1.32 [0.59-2.94],0.4943350658445447
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18453,48,1.58 [0.77-3.24],0.2141818316647226
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15505,38,1.46 [0.73-2.92],0.2871951367371073
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15505,38,1.35 [0.64-2.85],0.4355847327656295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,17965,48,1.02 [0.59-1.78],0.9350458631601212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15707,38,1.43 [1.12-1.83],0.0042785576727058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18453,48,0.87 [0.47-1.62],0.6653394356709716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18471,49,0.65 [0.27-1.61],0.3555061526597538
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,15926,38,0.97 [0.73-1.29],0.82453967883017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,15961,38,1.32 [0.38-4.57],0.6580369923503153
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16003,38,0.98 [0.62-1.55],0.943951496842725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18631,49,0.74 [0.30-1.83],0.5191122071470954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15505,38,0.94 [0.64-1.39],0.7658386441147924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18405,49,0.99 [0.77-1.28],0.9333162799606276
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18105,49,0.85 [0.55-1.32],0.4638214883557797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15538,37,0.99 [0.64-1.53],0.9514635814739386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,15961,38,0.96 [0.46-2.02],0.9228522239288433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15460,36,1.03 [0.66-1.59],0.9050268867298704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15707,38,0.83 [0.42-1.67],0.6040241513269886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,17994,48,1.05 [0.62-1.78],0.8644592137082846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",15929,37,0.93 [0.68-1.26],0.6448986724755899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15460,36,0.96 [0.59-1.56],0.8714865774296072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15460,36,1.26 [0.66-2.42],0.4822055743338512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18261,48,1.58 [0.23-10.82],0.6385119442974709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,15983,38,1.13 [0.42-3.08],0.804603582020414
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,15954,38,0.84 [0.20-3.61],0.8190005425688034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15266,36,0.52 [0.19-1.44],0.209036636494959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18446,49,0.83 [0.41-1.69],0.6050946028400876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18411,49,0.63 [0.44-0.91],0.0127806033303413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,17994,48,0.76 [0.42-1.38],0.3655267941246105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15538,37,1.07 [0.52-2.20],0.8517513394007092
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,15923,38,1.10 [0.71-1.69],0.6703939513772148
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15575,36,1.04 [0.66-1.64],0.8705824695294179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15499,37,1.10 [0.58-2.10],0.7646446742647691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15505,38,1.84 [0.51-6.68],0.3531570969473105
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18411,49,0.55 [0.17-1.76],0.3136534898487224
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,15860,38,1.01 [0.66-1.55],0.9644063765577038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18261,48,1.32 [1.03-1.69],0.0310841459587601
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15431,38,0.56 [0.19-1.59],0.2722931338721326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,15961,38,0.81 [0.47-1.38],0.4284452511352906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18411,49,1.43 [0.49-4.22],0.5134992528809923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15460,36,1.19 [0.95-1.48],0.133515153379441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18017,48,1.35 [0.91-2.00],0.1383025539907644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15460,36,1.18 [0.55-2.54],0.67690811017541
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18017,48,0.88 [0.52-1.52],0.6578400215952804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18641,50,0.40 [0.08-1.97],0.2582202360813281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,15991,37,0.71 [0.16-3.06],0.6421015530829037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18641,50,0.86 [0.40-1.85],0.706735214951987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15729,36,1.58 [0.64-3.94],0.3242813401099432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18412,50,1.30 [0.63-2.71],0.4777481443992846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15505,38,0.56 [0.21-1.50],0.2496862713077369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15505,38,1.11 [0.84-1.46],0.4770478889923514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,15983,38,1.06 [0.54-2.08],0.8585656406352624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18087,48,0.92 [0.77-1.09],0.3208445383990734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18405,49,1.35 [0.86-2.12],0.198791886602719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15460,36,1.50 [0.82-2.74],0.1914747196617556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,17994,48,1.07 [0.79-1.45],0.6565041278595187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18411,49,0.39 [0.20-0.76],0.0059483126735433
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,15991,37,0.37 [0.15-0.89],0.0264837642388959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18412,50,1.05 [0.51-2.19],0.8900973762335664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18584,48,1.10 [0.73-1.66],0.6356671685730981
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18412,50,0.80 [0.33-1.95],0.6217096227513165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16003,38,1.00 [0.71-1.40],0.9802786450257138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,15961,38,1.76 [1.21-2.55],0.0029721632423336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18533,49,0.98 [0.38-2.49],0.9620438868856244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18411,49,0.84 [0.34-2.06],0.6963440836272103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18105,49,1.12 [0.69-1.81],0.6437188712100683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15575,36,1.23 [0.55-2.73],0.615571099715376
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18575,49,1.17 [0.79-1.73],0.4345113344401157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",15983,38,1.14 [0.75-1.75],0.5453693592819158
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,15954,38,1.39 [0.59-3.29],0.4484333519230367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18368,49,1.11 [0.83-1.50],0.4785202401593125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18453,48,0.91 [0.55-1.48],0.6959294215761702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18405,49,0.95 [0.46-1.95],0.880892592382644
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,17994,48,1.00 [0.49-2.03],0.995304990614881
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18412,50,0.52 [0.19-1.42],0.2004777942866588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18575,49,3.01 [0.93-9.75],0.0661707817467978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18412,50,0.93 [0.74-1.17],0.5337711917011139
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18405,49,1.04 [0.77-1.41],0.7960415081603368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,15926,38,1.04 [0.78-1.40],0.7717218414824556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18556,48,1.05 [0.53-2.08],0.8996917282585337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18631,49,0.96 [0.65-1.43],0.8431867474924387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15538,37,1.00 [0.28-3.50],0.9970901427755452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15460,36,0.98 [0.52-1.87],0.9562973130086596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,15904,37,0.87 [0.60-1.25],0.439444870189823
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18321,48,1.00 [0.64-1.57],0.9894158179049526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18411,49,1.19 [0.72-1.96],0.489426213848777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15505,38,1.08 [0.74-1.58],0.6805720002551112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15460,36,1.08 [0.42-2.79],0.8751859044783684
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15460,36,1.55 [0.72-3.33],0.2597210153595719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18017,48,1.15 [0.63-2.11],0.6525850295635501
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15505,38,1.04 [0.37-2.97],0.9379110998332678
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18203,48,1.26 [0.79-2.02],0.3245043087140721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,15961,38,1.55 [0.84-2.85],0.1633493292343182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,17987,48,0.80 [0.47-1.37],0.4192970605023566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15707,38,1.08 [0.69-1.69],0.7449950066204185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,15929,37,0.90 [0.57-1.40],0.6300850108698997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18321,48,1.08 [0.48-2.41],0.8590977765281391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18411,49,1.30 [0.73-2.31],0.3762088190328028
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15707,38,0.84 [0.48-1.45],0.5265651366331322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15043,35,1.05 [0.80-1.38],0.705013534280976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18230,50,1.25 [0.85-1.83],0.2481029366408379
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18471,49,1.04 [0.56-1.96],0.8945914030282818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18321,48,1.03 [0.71-1.49],0.8624028619753562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15499,37,1.53 [0.97-2.41],0.0677483616803048
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,15954,38,0.96 [0.72-1.28],0.7967839606455066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15538,37,0.98 [0.62-1.56],0.936662736742506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18321,48,1.01 [0.58-1.78],0.9640718946254409
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,15945,37,3.26 [0.75-14.18],0.1153385596871394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,15954,38,1.50 [0.93-2.42],0.0981839888227721
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18411,49,0.75 [0.36-1.56],0.4393118503353624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18312,49,1.23 [0.86-1.78],0.2601767193795481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18533,49,1.10 [0.29-4.11],0.8915839738510583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15575,36,1.34 [0.70-2.57],0.3766243188509852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15499,37,1.16 [0.68-1.97],0.5837909955187843
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,15929,37,0.89 [0.51-1.55],0.6814550019717154
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,15961,38,0.98 [0.59-1.61],0.9212812626181868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15538,37,0.83 [0.52-1.32],0.4299072051619479
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18575,49,1.01 [0.85-1.20],0.8891493221578282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18310,47,0.99 [0.51-1.93],0.9736418442350732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15460,36,0.94 [0.55-1.60],0.8234982243326863
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18105,49,1.29 [0.98-1.71],0.0724204056230299
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,17987,48,1.19 [0.90-1.56],0.2191390392556658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18261,48,1.19 [0.94-1.49],0.1431690221032883
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,15961,38,1.02 [0.79-1.31],0.88432591086804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15707,38,1.08 [0.59-1.99],0.7934533805613715
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18087,48,0.97 [0.61-1.54],0.8843157425628805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15538,37,0.88 [0.40-1.93],0.7444276092603666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15404,38,0.97 [0.53-1.76],0.9220734927545796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18017,48,0.86 [0.56-1.34],0.5146196748832503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15505,38,0.99 [0.43-2.29],0.9844397608500696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15832,37,0.89 [0.32-2.47],0.8256348024995247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,15954,38,1.26 [0.58-2.72],0.5652126869290999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15460,36,1.10 [0.77-1.58],0.6095235750357952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18559,49,0.54 [0.24-1.19],0.1238239309043252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18411,49,1.58 [0.60-4.13],0.3543461142720334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18105,49,0.66 [0.38-1.12],0.1225714852441174
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15707,38,0.80 [0.50-1.29],0.3637858052661404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18411,49,1.27 [0.78-2.07],0.3423395537965052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18405,49,1.00 [0.64-1.58],0.9831899063318782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15631,36,1.00 [0.49-2.04],0.9953425074542208
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15431,38,2.81 [1.13-6.97],0.0255317895596709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18017,48,0.75 [0.44-1.27],0.2847383440676244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,15929,37,0.53 [0.17-1.69],0.285509298038597
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15499,37,1.14 [0.84-1.55],0.4025262256480242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15596,36,1.04 [0.53-2.04],0.9114110109221256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,15961,38,1.04 [0.68-1.60],0.8507722551304753
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18566,49,0.58 [0.16-2.19],0.4251764337317069
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,15961,38,0.57 [0.17-1.92],0.3646425808797591
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18412,50,1.52 [0.82-2.82],0.1873158206030571
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,15929,37,0.75 [0.27-2.07],0.5788160798182369
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,15929,37,1.32 [0.51-3.39],0.5645323176903517
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,15926,38,1.45 [0.73-2.88],0.2935568393115415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15431,38,0.79 [0.43-1.45],0.4505749123204602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,15926,38,1.26 [0.72-2.21],0.4253712609673662
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18641,50,0.75 [0.40-1.41],0.3698325593570627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,15929,37,1.30 [0.86-1.99],0.21729980927125
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,15983,38,0.96 [0.70-1.33],0.822866763727391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18552,48,1.12 [0.60-2.10],0.7222874343535577
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18321,48,0.51 [0.22-1.17],0.1110927941979108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18575,49,1.17 [0.76-1.81],0.4617222073316602
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18412,50,1.09 [0.75-1.60],0.6472554574020055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15431,38,1.32 [0.83-2.09],0.2463191512726709
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15431,38,0.79 [0.39-1.61],0.522378760991085
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15460,36,1.07 [0.65-1.77],0.7774779278997321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15631,36,0.95 [0.70-1.28],0.7218912873126249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18641,50,0.83 [0.59-1.17],0.2797937807845249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18471,49,0.79 [0.59-1.06],0.1114253862858574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,17994,48,0.44 [0.17-1.17],0.0999102218308192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18412,50,0.69 [0.28-1.73],0.4327831687767316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18641,50,0.55 [0.27-1.10],0.0925765383407982
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15431,38,0.64 [0.26-1.55],0.3214613152352338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15631,36,1.86 [0.70-4.94],0.213206244635686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,15991,37,0.89 [0.53-1.51],0.6705076541680968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15431,38,1.12 [0.68-1.83],0.6550322370085397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,15961,38,1.07 [0.82-1.40],0.6163954128635618
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18471,49,0.97 [0.79-1.19],0.7663042397761024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",17994,48,0.62 [0.33-1.16],0.1368505713729702
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15575,36,1.25 [0.75-2.09],0.39280610848638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15431,38,1.27 [0.85-1.89],0.2399371069206888
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15460,36,0.44 [0.21-0.91],0.0269810733609903
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15505,38,1.47 [0.82-2.65],0.1991329781596975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18641,50,0.67 [0.23-1.96],0.4612517077418802
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18411,49,1.22 [0.79-1.88],0.3610123951135207
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18411,49,0.64 [0.27-1.51],0.3048490467596261
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15538,37,0.92 [0.29-2.98],0.894982566959455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15631,36,1.66 [0.69-4.00],0.2625741758862082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16003,38,1.53 [0.47-5.00],0.4773752164147025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15505,38,0.90 [0.69-1.17],0.4336904906228285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,15882,36,0.85 [0.61-1.19],0.3509197680932947
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18017,48,0.79 [0.50-1.24],0.301920660848311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15431,38,0.57 [0.27-1.17],0.1231927455115634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15575,36,1.08 [0.68-1.70],0.7556658305416983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18295,48,1.02 [0.73-1.43],0.8888169189850585
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16003,38,1.20 [0.79-1.82],0.3870816891824795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",15983,38,1.05 [0.59-1.89],0.8606885533335997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18631,49,0.89 [0.32-2.48],0.8279449450450801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18550,49,1.73 [1.05-2.85],0.0310746440673993
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15810,37,0.79 [0.27-2.29],0.666477278044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15460,36,1.02 [0.59-1.76],0.9436667405672018
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15575,36,0.90 [0.49-1.63],0.7198377255816024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15505,38,1.01 [0.74-1.37],0.9602515519264492
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,15961,38,1.02 [0.77-1.33],0.9121824572929756
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,15929,37,0.91 [0.49-1.68],0.7698088420507768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15431,38,1.29 [1.02-1.63],0.0350476926940858
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18261,48,0.71 [0.31-1.61],0.4085937661460112
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15631,36,1.15 [0.53-2.49],0.7302808023156453
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16003,38,1.73 [0.48-6.26],0.4014052620958334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18170,46,1.15 [0.73-1.81],0.5452682900536198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",15961,38,1.06 [0.71-1.57],0.7888773880117904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18185,49,0.55 [0.27-1.12],0.0990127266391621
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18405,49,1.29 [0.87-1.91],0.2075157514218698
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18411,49,1.55 [0.68-3.55],0.2989567176996095
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15505,38,1.22 [0.74-2.02],0.4354032040053681
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18411,49,1.02 [0.56-1.86],0.9525971996310066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18412,50,0.98 [0.63-1.52],0.9242720799217312
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15631,36,1.48 [0.91-2.43],0.115414603213509
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15404,38,0.96 [0.63-1.48],0.8611990945159193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,15983,38,0.84 [0.26-2.68],0.7675825292668675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15460,36,0.78 [0.42-1.43],0.4236589606646895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18416,49,1.44 [1.00-2.07],0.048660843824975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15707,38,0.86 [0.55-1.34],0.5064975150576047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18261,48,0.91 [0.59-1.42],0.6903460212878556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18453,48,0.46 [0.19-1.13],0.0903609504757556
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18616,50,1.25 [0.72-2.18],0.4332331230391489
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18397,50,1.06 [0.66-1.69],0.8134064253055737
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18471,49,0.96 [0.72-1.28],0.7945743572924892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18411,49,1.53 [0.68-3.44],0.3003225077531932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18581,50,0.89 [0.54-1.44],0.623700498926189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18411,49,0.85 [0.34-2.13],0.7363741040094542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18267,48,0.87 [0.34-2.19],0.7622638337041728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",15954,38,1.05 [0.62-1.77],0.8675025686186115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15505,38,1.17 [0.60-2.28],0.6423948473645185
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",15954,38,1.12 [0.82-1.54],0.4762517321686874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,15954,38,0.99 [0.63-1.55],0.951573967172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15613,37,0.44 [0.11-1.83],0.2622235891570467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18017,48,0.99 [0.47-2.08],0.969030055315082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18412,50,1.14 [0.64-2.02],0.6663473923829923
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18412,50,1.25 [0.86-1.80],0.2364186659286047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,15926,38,0.74 [0.42-1.31],0.302564033871488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18582,49,0.83 [0.42-1.62],0.5801817078354718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,17994,48,1.05 [0.50-2.21],0.8909923398934723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,15954,38,0.55 [0.16-1.83],0.3274450316921812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18405,49,0.83 [0.61-1.13],0.2388774904934576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18557,49,0.69 [0.24-2.03],0.5029348258554189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18350,49,0.90 [0.53-1.53],0.6949734395873639
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18336,50,0.95 [0.84-1.07],0.4000625829671885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15460,36,0.96 [0.63-1.46],0.8423188273922562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15460,36,0.77 [0.44-1.36],0.3701529015900828
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15575,36,0.96 [0.50-1.83],0.8921750090332101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,17989,48,1.07 [0.84-1.37],0.5897908728825627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16003,38,0.97 [0.60-1.57],0.8997475817534151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,15954,38,1.25 [0.86-1.82],0.235363280305169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18380,48,1.04 [0.95-1.14],0.3949247395347767
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15538,37,0.77 [0.42-1.39],0.3787288817050788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15499,37,0.83 [0.39-1.77],0.6323621596124234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18105,49,1.09 [0.89-1.32],0.4108365128076924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18321,48,0.51 [0.10-2.74],0.4356866196177651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18453,48,1.54 [0.63-3.77],0.340498249773785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15505,38,0.94 [0.46-1.94],0.8753490349258187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15505,38,0.89 [0.30-2.65],0.828576695778413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18321,48,1.07 [0.53-2.17],0.840245900616006
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15538,37,1.09 [0.70-1.68],0.7139622753396255
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16003,38,0.75 [0.25-2.28],0.6094251553334983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18087,48,1.32 [0.64-2.73],0.4540244567392372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18471,49,0.72 [0.33-1.58],0.4165435995952146
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,15991,37,0.98 [0.42-2.27],0.9571306843067952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,15881,36,0.81 [0.55-1.17],0.2628378128940178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18575,49,0.95 [0.55-1.64],0.8407019118497498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18423,49,1.06 [0.81-1.38],0.6609107155289171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15707,38,1.13 [0.71-1.78],0.6059966186700987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",15991,37,0.83 [0.48-1.42],0.4954815995200758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15505,38,0.56 [0.19-1.60],0.2762024945511799
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,17994,48,0.80 [0.33-1.93],0.616131146017122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15505,38,1.12 [0.72-1.75],0.6143241902609478
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,15983,38,0.93 [0.52-1.68],0.8137032501229327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18321,48,1.38 [0.90-2.12],0.1446534632347177
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,15926,38,0.96 [0.66-1.40],0.8179471911713583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18453,48,0.92 [0.71-1.21],0.5708385734244257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15707,38,1.12 [0.75-1.66],0.5758541771086598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,15961,38,0.80 [0.53-1.21],0.2932424128070442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,15961,38,1.39 [0.71-2.72],0.3418573917603335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18412,50,1.09 [0.80-1.49],0.5854049415630462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18631,49,0.97 [0.74-1.27],0.8395692514629853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,15929,37,1.04 [0.80-1.35],0.7636766538860338
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18261,48,0.93 [0.49-1.75],0.8133262155862861
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15575,36,1.03 [0.68-1.55],0.8998591737356438
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18344,48,1.02 [0.80-1.30],0.9005041514649812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,17994,48,1.09 [0.72-1.64],0.6973008281479527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15431,38,1.16 [0.35-3.88],0.8063232982004169
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,15991,37,0.63 [0.29-1.38],0.2516716648523247
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,15926,38,1.38 [0.93-2.06],0.1126789769885182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18524,50,1.13 [0.51-2.49],0.7615675002974017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,17886,46,1.00 [0.75-1.35],0.9735655605246634
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15741,36,1.31 [0.80-2.15],0.2847511882957555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18105,49,0.87 [0.61-1.26],0.4668836692538998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18631,49,1.00 [0.68-1.46],0.999750515832354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18584,48,1.00 [0.65-1.52],0.9853906183659596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18105,49,1.14 [0.48-2.72],0.7618652256407524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18380,48,2.27 [0.79-6.59],0.1298873820779837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,15991,37,0.91 [0.49-1.69],0.7594036566040905
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,15991,37,0.72 [0.38-1.39],0.3333122658344072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18105,49,1.27 [0.82-1.97],0.2912661551511816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15575,36,0.90 [0.32-2.59],0.8491524865490196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18412,50,0.98 [0.73-1.33],0.9217949562117258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,15920,38,1.09 [0.73-1.62],0.6682256232367547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18105,49,0.88 [0.47-1.64],0.6827534738759933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15460,36,1.02 [0.50-2.09],0.960029171930514
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15631,36,1.00 [0.78-1.30],0.9812958818624335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,17994,48,1.07 [0.73-1.55],0.7350866147402122
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18575,49,0.92 [0.66-1.30],0.6482912372701394
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,15954,38,0.91 [0.47-1.75],0.7739255049596108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18478,49,2.44 [0.91-6.55],0.0776961301333349
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15460,36,1.30 [0.60-2.81],0.4997812911354189
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18405,49,0.93 [0.55-1.56],0.7790070335701491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16006,37,2.02 [0.66-6.18],0.2202827953306876
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15521,36,1.05 [0.67-1.65],0.8367632745708868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15505,38,1.43 [0.84-2.44],0.1869992931372418
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15538,37,2.16 [0.99-4.73],0.0527257577718306
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18500,49,1.00 [0.64-1.56],0.983628634738907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15505,38,0.62 [0.22-1.73],0.3592114253007625
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18352,50,0.73 [0.38-1.40],0.3480589589701126
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,15954,38,0.66 [0.29-1.50],0.3184699857128231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18329,49,0.95 [0.51-1.76],0.8600881587322692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18017,48,1.05 [0.83-1.33],0.6669943290743988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18584,48,0.63 [0.25-1.56],0.3179161645625811
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,17956,48,1.65 [1.16-2.37],0.0059867782923251
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15707,38,1.34 [0.53-3.40],0.5426934964589507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,15852,36,0.85 [0.26-2.74],0.7801867807229691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,15929,37,0.90 [0.47-1.70],0.7390560767602996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,15929,37,1.02 [0.91-1.16],0.7017228749320111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18261,48,1.14 [0.89-1.46],0.2891281218754448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18405,49,1.01 [0.69-1.50],0.9484128955626658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,17994,48,1.24 [0.76-2.03],0.392339210342574
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15431,38,0.90 [0.32-2.54],0.8437730630911455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,15961,38,1.27 [0.73-2.22],0.4007503135063205
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15575,36,1.01 [0.56-1.84],0.9681875460711488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18321,48,1.51 [1.00-2.26],0.0481174375554657
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18231,48,1.25 [0.63-2.48],0.529595600588281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18185,47,1.27 [0.63-2.59],0.5063359162844101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18405,49,1.72 [1.08-2.74],0.0226981026100907
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15505,38,1.46 [0.94-2.26],0.08849873709355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18405,49,0.99 [0.74-1.32],0.9422743734163752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,17994,48,0.89 [0.57-1.39],0.6006631705600725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15077,36,0.97 [0.72-1.30],0.8185575608520752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18017,48,0.81 [0.35-1.91],0.6370647649516026
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18304,49,1.23 [0.56-2.71],0.6017583578730965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15392,38,1.05 [0.59-1.87],0.8707534423556218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,15983,38,0.91 [0.62-1.33],0.6281274595450446
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15575,36,1.05 [0.71-1.55],0.8140237468427718
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18405,49,0.93 [0.45-1.89],0.8302702548341564
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18017,48,1.44 [0.73-2.82],0.2910287958522445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18087,48,0.86 [0.51-1.46],0.5839540319938521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15505,38,1.51 [0.96-2.37],0.0748820820787086
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18261,48,1.07 [0.77-1.47],0.6995377629215829
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18450,49,1.04 [0.79-1.39],0.7674109326383578
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15479,38,1.79 [1.10-2.90],0.0192903922085415
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,15983,38,0.85 [0.30-2.41],0.7592967593967704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,15991,37,0.59 [0.14-2.44],0.4646798814044789
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18641,50,0.95 [0.39-2.28],0.9056624796499324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,15929,37,1.41 [0.78-2.58],0.256017485370918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,15929,37,0.59 [0.12-2.97],0.5189207750848521
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18373,49,0.52 [0.18-1.48],0.2195882222870192
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18200,48,1.90 [0.92-3.93],0.0829576737735242
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,15954,38,1.94 [0.95-3.93],0.0675175956742066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18641,50,1.27 [0.47-3.43],0.6340469107494588
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,15983,38,0.70 [0.25-1.94],0.490373237256717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15631,36,1.02 [0.59-1.77],0.9358300690663992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,17923,47,1.17 [0.74-1.85],0.503906953020068
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15707,38,1.05 [0.50-2.20],0.9001869041428507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18405,49,0.91 [0.56-1.50],0.7157565927479987
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18509,48,1.11 [0.88-1.40],0.3831985924860598
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18575,49,1.17 [0.60-2.30],0.6392529931688566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,15926,38,0.62 [0.29-1.33],0.2197336923268807
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18017,48,0.95 [0.58-1.56],0.8285754509696271
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15538,37,1.79 [1.02-3.15],0.0426536899637931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15460,36,0.91 [0.66-1.27],0.5898961192672983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16006,37,1.07 [0.42-2.71],0.8909932837166832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18320,50,1.50 [0.84-2.67],0.1718790759436569
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18426,50,0.86 [0.33-2.25],0.7646744215633021
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15683,33,0.60 [0.18-2.02],0.4061739164720971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,15983,38,0.92 [0.51-1.65],0.7714481939841451
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,15983,38,1.01 [0.75-1.34],0.9721688515667865
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,15983,38,0.99 [0.68-1.44],0.968699582137968
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,15926,38,0.98 [0.59-1.63],0.9348112524329032
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15460,36,1.14 [0.71-1.84],0.5768964754455017
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18105,49,1.14 [0.87-1.50],0.330480864665024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15460,36,0.82 [0.51-1.31],0.4006393755000562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15499,37,0.96 [0.55-1.67],0.8852212282948894
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,15926,38,1.37 [0.89-2.10],0.15504563806317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18405,49,1.19 [0.68-2.07],0.5397896869016239
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18017,48,0.75 [0.41-1.37],0.3476953857259736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15631,36,0.85 [0.55-1.31],0.467111464625082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,17994,48,0.97 [0.62-1.52],0.8943834477749172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18105,49,1.15 [0.76-1.74],0.5131488130241717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15575,36,1.30 [0.94-1.80],0.1078721812230024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,17994,48,0.85 [0.48-1.51],0.5848982169853159
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15707,38,1.01 [0.57-1.80],0.9640490599462544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15505,38,1.61 [0.63-4.13],0.3199688021156385
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,15926,38,1.45 [0.93-2.25],0.1016997453026652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15538,37,1.40 [0.78-2.51],0.2594568640551664
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15499,37,1.22 [0.48-3.08],0.6706322646775387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,17994,48,0.85 [0.47-1.52],0.584834247605732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15505,38,1.23 [0.86-1.75],0.2511822869633643
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15707,38,0.79 [0.42-1.49],0.4654992965157941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,17994,48,1.15 [0.56-2.37],0.6998001293861211
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18533,49,1.24 [0.76-2.01],0.394460917603143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18017,48,0.63 [0.28-1.41],0.2622254636442108
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15431,38,1.48 [0.81-2.69],0.2017244378201363
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,17994,48,1.00 [0.64-1.56],0.9855715865349096
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,15961,38,1.15 [0.54-2.42],0.7221842834745404
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,17991,48,1.41 [0.86-2.34],0.1759772157352416
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,15961,38,0.92 [0.61-1.40],0.7045651854849133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15460,36,0.90 [0.43-1.91],0.7861161519911486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15431,38,0.93 [0.46-1.87],0.8418333418437274
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15575,36,0.93 [0.57-1.51],0.76303643213121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18321,48,0.96 [0.68-1.34],0.8088317813084178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18321,48,0.85 [0.52-1.37],0.492883510964001
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,15929,37,1.14 [0.71-1.81],0.588158436969832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15505,38,1.29 [0.91-1.81],0.1523347091225303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15538,37,0.95 [0.69-1.30],0.7377104237306223
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,15926,38,1.32 [0.84-2.09],0.2293117282512147
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18087,48,1.47 [1.01-2.15],0.0464244230190104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15538,37,0.50 [0.12-2.11],0.343745172020362
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,15961,38,0.82 [0.48-1.41],0.4780588303492711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18325,49,1.21 [0.75-1.96],0.4383922935116972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18641,50,1.13 [0.74-1.73],0.5600386601578942
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18641,50,1.25 [0.87-1.80],0.2363039642139637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,15926,38,0.74 [0.32-1.70],0.47193710953218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18411,49,1.19 [0.73-1.93],0.49484592080058
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15505,38,1.21 [0.67-2.18],0.5271278914800908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18411,49,1.30 [0.56-3.01],0.5367432356114996
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REN,Renin,18412,50,0.87 [0.63-1.20],0.4012094425004874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15505,38,0.94 [0.41-2.14],0.8831827567686175
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15431,38,1.02 [0.43-2.45],0.9565782725978712
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18321,48,0.99 [0.49-1.99],0.9803055779207922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18378,49,1.37 [0.80-2.35],0.2522610250909084
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15460,36,1.15 [0.63-2.11],0.6413963005865047
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,15926,38,1.11 [0.28-4.49],0.8784501447143909
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,15961,38,0.88 [0.59-1.32],0.5354050387943536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15707,38,1.20 [0.80-1.79],0.3688574491252691
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18575,49,1.12 [0.51-2.46],0.7830339432559473
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18575,49,1.01 [0.41-2.52],0.981192007345052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,15961,38,0.98 [0.58-1.66],0.9348137161528596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18105,49,1.09 [0.77-1.55],0.6305141300031081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18166,48,1.01 [0.81-1.26],0.9241444010837064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15505,38,1.20 [0.69-2.07],0.513129211643747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15631,36,1.04 [0.54-1.98],0.9106714661576332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18535,48,1.15 [0.75-1.76],0.5258467130646399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,15983,38,0.97 [0.71-1.33],0.8644531358633458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15460,36,1.18 [0.78-1.77],0.4381817690764896
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,15961,38,0.60 [0.19-1.89],0.3791679305543655
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15607,36,1.09 [0.60-2.00],0.770514017754959
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16003,38,1.53 [0.49-4.77],0.4678410733817204
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15538,37,1.49 [0.85-2.62],0.1668166101470037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18323,50,1.31 [1.11-1.54],0.0011890691593575
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15497,36,3.10 [1.33-7.19],0.0084832475020114
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,15896,38,1.20 [0.51-2.83],0.671171074180667
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,15961,38,0.83 [0.41-1.65],0.5904984945438244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18556,50,1.41 [0.56-3.53],0.4682411233592187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15538,37,1.49 [0.55-4.09],0.4350947160892935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15505,38,1.02 [0.48-2.21],0.9516302701956824
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15505,38,1.36 [0.70-2.64],0.3682778668338243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15707,38,1.04 [0.66-1.63],0.8746020051882901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,17994,48,1.10 [0.75-1.61],0.6256538171598524
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15707,38,1.55 [1.16-2.07],0.0030372185338245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15538,37,0.89 [0.58-1.37],0.6000892749215924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18411,49,0.46 [0.15-1.38],0.1647455278357366
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18575,49,0.88 [0.29-2.69],0.8212601338231527
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15538,37,0.94 [0.16-5.45],0.9419883040730462
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18412,50,1.14 [0.52-2.52],0.7467386687432906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18321,48,0.79 [0.42-1.48],0.4589138776955849
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15505,38,1.64 [0.79-3.38],0.1837448937712281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15707,38,1.11 [0.73-1.67],0.6322690485070975
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15575,36,0.90 [0.39-2.09],0.8065915539894372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15538,37,1.15 [0.54-2.49],0.7142205962882566
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15460,36,0.98 [0.44-2.17],0.9571706785285892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15575,36,0.92 [0.71-1.19],0.5440953076256746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,17994,48,0.51 [0.25-1.02],0.0572828210523245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,17994,48,0.93 [0.63-1.37],0.7178235454196356
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15499,37,1.02 [0.72-1.46],0.8961205784523675
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18261,48,1.06 [0.50-2.25],0.8752529675036472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18584,48,1.39 [0.57-3.38],0.4687393257150395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18321,48,1.07 [0.44-2.60],0.8773324656497062
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15460,36,0.63 [0.27-1.45],0.2758157534358291
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",15961,38,0.98 [0.70-1.37],0.9002777124191216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18584,48,0.71 [0.32-1.56],0.3960860571273512
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,17994,48,0.98 [0.76-1.27],0.8847354385116064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18575,49,1.09 [0.73-1.63],0.6695213825245836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15460,36,0.57 [0.18-1.77],0.3264728489812778
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18277,50,1.63 [1.15-2.31],0.0060597196728029
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18143,48,1.15 [0.82-1.62],0.4135792551994726
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15505,38,0.51 [0.19-1.32],0.1642054078847928
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,15961,38,1.35 [0.79-2.31],0.2725528114559616
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,17987,48,1.10 [0.74-1.64],0.6285237171461457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,15926,38,1.48 [1.00-2.19],0.048763670077782
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18453,48,1.07 [0.68-1.69],0.7726509643137954
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,15961,38,0.98 [0.51-1.85],0.9394807992772918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18087,48,1.36 [0.94-1.97],0.1045839958805395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16006,37,0.93 [0.29-2.95],0.9007773056424878
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,15961,38,1.03 [0.33-3.20],0.9591722338568976
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15499,37,1.29 [0.77-2.16],0.3413142107347429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18405,49,1.07 [0.76-1.51],0.7031668300599638
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15707,38,1.04 [0.70-1.56],0.8464789303378488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,15934,38,1.04 [0.78-1.38],0.7864572534206687
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15460,36,1.32 [0.70-2.50],0.3949226758373186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15460,36,1.46 [0.93-2.30],0.0972506601177539
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15707,38,0.65 [0.37-1.15],0.138279852183171
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,15961,38,1.51 [0.69-3.33],0.306841089446361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,15961,37,0.92 [0.38-2.23],0.8493620954115719
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18321,48,0.95 [0.70-1.29],0.7452797891496077
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18575,49,0.95 [0.41-2.20],0.9070513897742652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18017,48,0.85 [0.50-1.45],0.5543547825552483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,17910,47,1.22 [0.54-2.75],0.6246443674872285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18641,50,0.77 [0.42-1.41],0.3967618523436452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18575,49,1.05 [0.43-2.56],0.9202075187478104
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18507,48,1.02 [0.46-2.25],0.9559112123108788
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18411,49,1.34 [0.63-2.87],0.450406215332081
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18418,49,1.22 [0.75-2.00],0.4207039490385516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15460,36,0.98 [0.34-2.86],0.9705838238909922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15631,36,1.67 [0.50-5.50],0.402059757398871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18450,49,0.80 [0.57-1.13],0.2023995507701329
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18105,49,1.37 [0.78-2.40],0.2733134921305769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15499,37,0.94 [0.60-1.47],0.7875604571898441
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18535,48,0.77 [0.44-1.35],0.3592845062710109
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15499,37,1.25 [0.72-2.17],0.423209553553997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15575,36,2.03 [0.86-4.80],0.1071648808981127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15575,36,1.09 [0.47-2.54],0.8353606960756834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15499,37,1.21 [0.67-2.18],0.5189074053719075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15538,37,0.94 [0.44-1.99],0.8663703596294898
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,17994,48,0.96 [0.68-1.37],0.8235523941733368
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15488,37,0.81 [0.42-1.55],0.5186642913949282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,15983,38,1.02 [0.33-3.20],0.9662831921199584
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15538,37,0.87 [0.58-1.30],0.4946785263356194
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18405,49,0.83 [0.51-1.33],0.433037987010342
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15575,36,1.35 [0.71-2.57],0.3601922323316054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18412,50,1.00 [0.53-1.88],0.9916058993802748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18412,50,0.67 [0.40-1.12],0.1276284479284792
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,15926,38,1.05 [0.80-1.37],0.7465228802799196
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,15929,37,0.63 [0.34-1.15],0.1314390900448555
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15631,36,1.14 [0.49-2.65],0.7544616757815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15538,37,1.13 [0.74-1.71],0.5753348448670003
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15538,37,1.36 [0.63-2.95],0.4349840359791666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18641,50,0.97 [0.59-1.60],0.9203297225031688
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16006,37,4.06 [1.56-10.55],0.0040613928882303
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16006,37,1.17 [0.28-4.89],0.8278156840623674
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18500,49,0.94 [0.60-1.48],0.7967864640156328
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18405,49,0.72 [0.28-1.83],0.4880114487771322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18412,50,1.65 [0.65-4.21],0.2927154874157118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15631,36,1.18 [0.59-2.36],0.6346864339674074
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18321,48,0.86 [0.33-2.22],0.7558055444088866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18575,49,0.87 [0.38-2.00],0.7401350859458531
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15505,38,1.51 [0.56-4.11],0.4168643272279845
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18581,50,0.97 [0.38-2.45],0.9483985927589836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,15961,38,1.29 [0.92-1.83],0.1421366686807549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15707,38,1.47 [1.03-2.10],0.0350623714551198
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,15922,38,1.26 [0.51-3.14],0.6172596481259162
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18321,48,0.43 [0.15-1.18],0.1016411743706244
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15712,36,4.53 [0.39-52.45],0.2264911583869563
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18641,50,0.68 [0.37-1.22],0.1953964972606839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,17897,50,1.16 [0.95-1.43],0.1481741608854279
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,15962,36,0.56 [0.06-5.05],0.6023768188817317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15718,37,1.21 [0.32-4.63],0.7818667797177867
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15771,37,1.14 [0.42-3.08],0.7974071653498145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16006,37,0.44 [0.06-3.30],0.4210523503603711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16006,37,6.50 [1.53-27.68],0.0113443028683784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18243,48,0.76 [0.52-1.11],0.1549996154735594
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18356,49,1.10 [0.84-1.44],0.5032843555008917
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18087,48,1.16 [0.67-2.00],0.5926017833201267
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18513,49,0.98 [0.64-1.51],0.9355447323854535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18631,49,1.07 [0.72-1.60],0.7402928365443507
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18261,48,1.49 [0.68-3.30],0.3223903910466467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,15981,37,0.83 [0.10-7.18],0.8676115301947421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,15981,37,1.44 [0.48-4.33],0.5134227293655143
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18641,50,0.79 [0.54-1.14],0.2005472624627808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,15983,38,0.79 [0.48-1.29],0.3397235348971348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15769,36,1.92 [0.63-5.88],0.2542779838975808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15702,36,1.05 [0.10-11.36],0.9694041519635486
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,15981,37,1.17 [0.21-6.46],0.8582055870408386
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15707,38,0.94 [0.74-1.20],0.6176877144472435
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15604,36,0.21 [0.06-0.71],0.0119186922288318
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,15929,37,0.91 [0.51-1.62],0.7378441593295322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18017,48,1.14 [0.78-1.67],0.5073311627244579
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18194,48,1.30 [0.57-2.98],0.5335157410028717
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15575,36,1.55 [0.62-3.87],0.3430777689941052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18453,48,2.24 [0.92-5.44],0.0750227676269723
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18321,48,0.96 [0.33-2.81],0.9368187292524714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18321,48,0.98 [0.69-1.40],0.9284581061680218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18194,48,1.60 [1.00-2.54],0.049104820168466
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15631,36,0.59 [0.26-1.32],0.1969153513469732
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,17994,48,0.73 [0.42-1.28],0.271202006790659
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,17994,48,0.69 [0.41-1.17],0.1701444419832397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18412,50,0.63 [0.43-0.91],0.01478200655941
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15735,38,0.50 [0.27-0.93],0.0273370059776286
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,17994,48,0.97 [0.74-1.26],0.7968531734276834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18405,49,0.94 [0.60-1.47],0.7799523723901103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15499,37,1.09 [0.67-1.76],0.7352831419725316
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,15929,37,0.82 [0.41-1.64],0.575651749122932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15612,38,0.88 [0.62-1.25],0.4895325535477056
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,15954,38,1.18 [0.75-1.87],0.477189287280179
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16003,38,0.65 [0.34-1.25],0.1956833008818055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15431,38,1.14 [0.89-1.46],0.2866021723388336
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15432,36,1.35 [1.08-1.69],0.0077619408758308
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15505,38,1.01 [0.49-2.08],0.9723301947262624
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,15991,37,1.83 [0.66-5.05],0.2465512842061752
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18450,49,1.06 [0.79-1.44],0.6819249849351322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15707,38,1.53 [0.87-2.70],0.1424450630414771
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18424,48,0.94 [0.54-1.64],0.8243085677598252
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18471,49,0.71 [0.39-1.30],0.27075878027313
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18405,49,0.79 [0.36-1.73],0.5639159652125727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18017,48,0.74 [0.47-1.17],0.1989960097545939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18411,49,1.05 [0.83-1.33],0.667571588869653
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18584,48,0.64 [0.30-1.40],0.2669818880629195
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18412,50,1.43 [0.59-3.49],0.4314388903757646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15538,37,1.35 [0.67-2.69],0.3980644654517038
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18558,48,0.54 [0.23-1.24],0.1450920137837281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15538,37,1.42 [0.72-2.80],0.3148529707623587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18458,48,0.96 [0.62-1.50],0.8657110677582234
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18346,48,1.14 [0.67-1.96],0.6255596102133253
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15505,38,1.01 [0.70-1.45],0.9598044639354034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18321,48,1.08 [0.80-1.44],0.6188314236560797
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18017,48,0.59 [0.32-1.08],0.0862991226420705
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18105,49,0.68 [0.42-1.10],0.114683461246476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18233,48,0.82 [0.57-1.18],0.2865255189777714
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18471,49,0.95 [0.75-1.21],0.6943943331604127
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15460,36,0.73 [0.28-1.86],0.5064000531212082
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,15961,38,0.95 [0.71-1.27],0.732698051100334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18105,49,0.71 [0.48-1.04],0.0780929429132002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,17994,48,0.96 [0.48-1.93],0.9150164828364042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18405,49,0.75 [0.48-1.16],0.1991040534146295
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,17994,48,0.71 [0.45-1.12],0.1373083823791751
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15460,36,1.14 [0.37-3.53],0.815905006836227
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,15926,38,1.37 [1.00-1.88],0.0536270469767311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18017,48,0.99 [0.62-1.58],0.9702326390137772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15575,36,1.29 [0.78-2.12],0.3227366172637685
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18017,48,0.72 [0.45-1.15],0.1721581673269769
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15431,38,0.77 [0.41-1.44],0.4097701029194983
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15431,38,0.75 [0.34-1.62],0.463028532378128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18017,48,1.76 [1.02-3.04],0.0434526632390352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18405,49,0.79 [0.47-1.31],0.3538475189468182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15575,36,1.06 [0.68-1.65],0.8067348886920103
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,15991,37,0.75 [0.38-1.49],0.409534343766839
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15460,36,1.27 [0.87-1.86],0.2173423244818758
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15631,36,0.85 [0.58-1.25],0.4131922384952413
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,15929,37,0.79 [0.38-1.66],0.5393544913603519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15431,38,0.90 [0.50-1.63],0.7335488231359846
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18017,48,0.96 [0.58-1.58],0.8808303586432944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15505,38,1.88 [0.75-4.72],0.1791877751495042
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18584,48,0.60 [0.33-1.08],0.0903260781806658
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18087,48,0.85 [0.40-1.80],0.6788149509964796
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15707,38,1.09 [0.77-1.56],0.6136863559386033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,15929,37,0.96 [0.65-1.41],0.8354157919748101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,15878,37,1.21 [0.55-2.66],0.6438223667103429
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,17994,48,1.00 [0.74-1.36],0.9975721899669008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,15926,38,1.01 [0.65-1.58],0.9636050553531808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,15926,38,0.74 [0.39-1.38],0.3426679301357722
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18321,48,0.89 [0.25-3.18],0.8551327101514257
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18017,48,0.80 [0.54-1.17],0.2532432241442406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15431,38,0.93 [0.50-1.73],0.8279455837363805
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,15929,37,1.27 [0.86-1.88],0.2285439208049245
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18584,48,1.40 [0.65-3.03],0.3863247461957887
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18471,49,1.43 [0.77-2.66],0.2550498796074736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18482,49,0.50 [0.29-0.85],0.011083504196176
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15505,38,1.26 [0.83-1.91],0.281182776955311
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18437,49,0.61 [0.43-0.87],0.0057394853187458
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,15926,38,1.31 [0.99-1.74],0.060073496109818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15499,37,0.81 [0.46-1.43],0.4713602974533536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,15922,38,0.92 [0.64-1.32],0.6539317602042818
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18412,50,1.02 [0.76-1.35],0.9163704178648922
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15499,37,0.78 [0.39-1.55],0.477433321376836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18453,48,0.96 [0.73-1.27],0.7966409326697734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,15961,38,1.19 [0.71-2.01],0.5086753518495637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15631,36,1.05 [0.79-1.38],0.7527635839281727
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18261,48,0.98 [0.67-1.44],0.916840336160106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15538,37,0.74 [0.26-2.11],0.572414256357445
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',15954,38,1.45 [1.01-2.07],0.0421739989708768
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15460,36,1.35 [0.94-1.94],0.1075031220090164
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15631,36,1.16 [0.64-2.09],0.6192897961630515
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,15929,37,1.26 [0.67-2.36],0.4708502384770013
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,15926,38,1.09 [0.77-1.53],0.6239303862781231
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15538,37,0.90 [0.30-2.66],0.8479984125705526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18412,50,1.15 [0.80-1.65],0.4666710537322495
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18071,49,1.69 [1.03-2.76],0.0363418970849531
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18411,49,1.15 [0.60-2.21],0.6713225227634121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16003,38,0.24 [0.08-0.69],0.0082028328271966
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,15961,38,1.65 [1.07-2.56],0.0239993089130387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,17994,48,1.44 [0.70-2.98],0.324476830074431
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18502,48,1.09 [0.74-1.60],0.6586193322939949
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18392,50,0.73 [0.37-1.43],0.3536139945757339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18392,50,1.37 [0.72-2.62],0.3352387418637397
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15575,36,1.45 [0.93-2.24],0.0973933428195128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,15923,38,1.11 [0.31-3.97],0.8703779985176503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15575,36,1.99 [0.60-6.56],0.2579275545104337
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,15961,38,2.15 [1.17-3.95],0.0139871734782008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,15961,38,1.21 [0.77-1.89],0.4121667921672007
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18453,48,0.82 [0.58-1.15],0.2524825139854536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18436,49,1.71 [0.88-3.34],0.1133338047350374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15631,36,1.04 [0.68-1.57],0.8671537620679857
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,15983,38,1.49 [0.63-3.54],0.3650657496314873
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18411,49,1.50 [0.84-2.68],0.1709219671487472
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15631,36,0.56 [0.21-1.49],0.2427947847043587
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18405,49,0.99 [0.67-1.47],0.9641085174380406
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18411,49,1.03 [0.50-2.13],0.9305670208258676
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18584,48,0.85 [0.52-1.37],0.4960349331600749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15460,36,1.10 [0.47-2.56],0.8307908566041627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18344,48,1.20 [0.45-3.16],0.7135541771351526
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18471,49,0.90 [0.47-1.73],0.7594626064041471
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,15929,37,0.90 [0.75-1.08],0.249379076524152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18261,48,1.48 [0.56-3.94],0.4302247651529864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18411,49,0.74 [0.33-1.63],0.4495861956389916
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18330,49,0.76 [0.36-1.63],0.4861227592050361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18610,49,0.99 [0.55-1.79],0.9664801853883626
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15505,38,1.17 [0.59-2.35],0.6514933109187232
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15431,38,0.97 [0.58-1.62],0.9089097443978178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15707,38,1.20 [0.90-1.60],0.2255909183629689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,15954,38,0.94 [0.57-1.54],0.7934432143765969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18105,49,0.95 [0.72-1.26],0.7432904956750099
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15499,37,1.12 [0.45-2.83],0.8053665474662258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,15954,38,1.46 [0.84-2.54],0.1745144494861872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18424,48,1.01 [0.82-1.25],0.9352037908040188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18321,48,1.39 [0.95-2.03],0.092177747785535
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18405,49,0.99 [0.73-1.34],0.9327060143364542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,15983,38,0.92 [0.42-2.02],0.8372518573415317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18017,48,0.82 [0.49-1.37],0.4565834702890256
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15505,38,1.01 [0.42-2.44],0.9827884269996716
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18392,50,0.99 [0.81-1.21],0.9270246359379324
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18500,49,0.54 [0.30-0.98],0.0424537242081885
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15431,38,0.65 [0.20-2.12],0.4786529870580133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,15929,37,0.95 [0.51-1.78],0.8722453717785387
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15631,36,1.10 [0.61-1.98],0.7522968195569375
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18321,48,1.07 [0.60-1.91],0.8162530509152572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18641,50,1.13 [0.50-2.54],0.766395216365332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15505,38,1.58 [1.15-2.18],0.0053751438884339
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,15991,37,0.73 [0.25-2.18],0.577298685898481
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,15926,38,0.59 [0.22-1.58],0.2922503234632914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18233,48,1.11 [0.74-1.67],0.603458218655804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15505,38,0.90 [0.60-1.37],0.6336692312201357
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18321,48,1.03 [0.85-1.24],0.753879095910965
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15431,38,0.88 [0.53-1.47],0.6263045014494748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18575,49,1.74 [1.04-2.89],0.0340954700079268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18389,49,0.98 [0.33-2.87],0.9715085081932838
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15499,37,1.16 [0.80-1.68],0.4186736903303748
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18376,49,1.15 [0.78-1.69],0.4790612139550115
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18087,48,1.16 [0.81-1.65],0.4137182836727184
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18017,48,1.02 [0.67-1.54],0.9388022665984488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18412,50,1.08 [0.81-1.44],0.5809858347055334
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15431,38,0.84 [0.58-1.23],0.3718765787727519
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,17994,48,1.19 [0.80-1.75],0.3883098515025593
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15575,36,1.41 [0.80-2.47],0.229483078643904
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,15954,38,1.35 [0.71-2.56],0.3657498593980663
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18321,48,0.90 [0.56-1.43],0.6463393580434498
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15505,38,1.37 [0.76-2.46],0.2888201088443218
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,17994,48,0.66 [0.40-1.08],0.0952414777489258
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15505,38,0.76 [0.39-1.45],0.3976163928530511
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18405,49,0.94 [0.55-1.62],0.8275125333703871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,15961,38,0.93 [0.63-1.39],0.7395356100034562
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,17994,48,0.67 [0.35-1.30],0.2409631717197677
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,15929,37,1.31 [0.64-2.70],0.4640301043748791
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,17994,48,1.05 [0.76-1.45],0.788632798867853
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18575,49,1.00 [0.82-1.21],0.977260680381384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18405,49,1.03 [0.66-1.59],0.9021255295952866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15505,38,0.99 [0.60-1.63],0.9639211669905352
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18575,49,0.95 [0.59-1.54],0.8471134898659187
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",15961,38,1.26 [0.80-1.96],0.3199315022793785
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18087,48,1.01 [0.59-1.72],0.9695286201491332
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18411,49,0.85 [0.34-2.10],0.7216312622693455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,15926,38,1.03 [0.47-2.25],0.9400990462261476
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15560,36,0.83 [0.32-2.14],0.7016112034043935
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15575,36,1.16 [0.73-1.86],0.521995691286729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,15929,37,0.65 [0.24-1.74],0.3914139254701133
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15631,36,0.66 [0.36-1.21],0.1802631828788432
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15499,37,1.32 [0.87-1.99],0.1858940712815459
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,15954,38,1.33 [0.76-2.33],0.3220647445192457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,15983,38,0.95 [0.61-1.47],0.8241372239637906
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15707,38,0.93 [0.69-1.25],0.6196290406091378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18321,48,1.03 [0.83-1.29],0.7591091724597974
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16316,42,nan [nan-nan],
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,15926,38,0.82 [0.37-1.80],0.6242039606902814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18321,48,1.05 [0.52-2.14],0.8894313950373101
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15431,38,0.74 [0.44-1.24],0.2506201090563235
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,15943,37,1.14 [0.57-2.31],0.7083635595384037
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18105,49,1.23 [0.87-1.74],0.2360960939638589
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15707,38,0.99 [0.57-1.72],0.977713832027764
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18017,48,1.06 [0.77-1.48],0.7061871559495367
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15575,36,0.98 [0.64-1.52],0.9335996695129886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",15926,38,1.07 [0.48-2.37],0.8707311117123736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,15954,38,0.92 [0.55-1.55],0.7551343472682837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18017,48,1.42 [0.85-2.39],0.181925732031835
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18321,48,1.03 [0.77-1.36],0.8505973533699842
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18405,49,1.06 [0.77-1.45],0.7367714051013836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15631,36,1.00 [0.68-1.48],0.9886908858080918
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18261,48,1.02 [0.79-1.33],0.8543323325971814
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18261,48,1.01 [0.74-1.39],0.9366924148883836
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,17994,48,1.04 [0.77-1.40],0.8213133684811833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15575,36,1.18 [0.66-2.11],0.585767723022565
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18238,48,0.97 [0.75-1.26],0.8367430770576106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18087,48,0.99 [0.71-1.38],0.9415182560895692
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15688,38,1.10 [0.46-2.67],0.8254862413408666
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18610,49,0.66 [0.28-1.55],0.3371421321765465
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,15983,38,1.69 [0.80-3.56],0.1674419776992421
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15707,38,1.20 [0.78-1.84],0.4020319247068606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,15983,38,0.82 [0.30-2.25],0.6931549767554682
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18017,48,1.04 [0.88-1.23],0.6579218007040137
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15575,36,0.58 [0.21-1.60],0.2930357040237834
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,15926,38,1.14 [0.78-1.64],0.5027173630340467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18017,48,0.83 [0.60-1.16],0.2784866095523057
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15460,36,0.92 [0.42-2.00],0.8346834610111474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18453,48,1.15 [0.36-3.64],0.8125509675968388
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15505,38,1.37 [0.50-3.72],0.5367003864708499
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15678,38,0.74 [0.47-1.16],0.1883540080595871
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15575,36,0.88 [0.52-1.51],0.6481044017457145
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15707,38,1.59 [0.99-2.53],0.0528333488306872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16006,37,0.43 [0.10-1.81],0.2481216207354066
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15499,37,1.33 [0.90-1.96],0.1489105521250978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18335,49,0.88 [0.62-1.24],0.4644484351210747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18450,49,0.97 [0.62-1.52],0.9111285983205152
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18418,49,1.29 [0.69-2.43],0.428490687978449
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18387,49,1.06 [0.47-2.39],0.8956107339559243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18399,48,0.72 [0.34-1.50],0.3778573576699542
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18501,49,2.12 [1.16-3.88],0.0145645931502763
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,15926,38,0.99 [0.73-1.34],0.9586541627001866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18405,49,0.80 [0.44-1.46],0.4672453787798651
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18598,49,1.00 [0.52-1.92],0.9917684803281236
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,15926,38,0.84 [0.46-1.53],0.5694303191943075
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18330,49,0.95 [0.37-2.47],0.919038063975011
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15505,38,1.52 [0.46-4.98],0.489535517013912
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18453,48,1.20 [0.57-2.53],0.640948136892612
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18641,50,1.15 [0.49-2.67],0.7507057989930102
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18379,49,1.32 [0.95-1.86],0.1021824771731455
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16003,38,2.10 [0.69-6.42],0.1915076339017399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15404,38,1.10 [0.80-1.53],0.54980898183088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18412,50,1.68 [0.78-3.61],0.1831489538698381
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18411,49,0.98 [0.51-1.91],0.959144474669106
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18446,49,0.86 [0.49-1.51],0.6015544741758545
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18329,50,1.31 [0.60-2.85],0.500921955838548
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18087,48,1.54 [0.80-2.93],0.1936960511210155
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15460,36,0.94 [0.67-1.30],0.6974678992735275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15387,38,1.02 [0.41-2.58],0.960448347956426
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,15887,38,1.00 [0.70-1.44],0.9891228372248384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18575,49,1.53 [0.65-3.61],0.3312554273253997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,17883,47,1.03 [0.83-1.28],0.7737293237769347
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18641,50,0.76 [0.45-1.30],0.316005048467999
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",17989,48,0.72 [0.40-1.29],0.2705115192085875
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15707,38,1.47 [0.87-2.49],0.1514574026584757
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18500,49,1.07 [0.59-1.94],0.8233324615256994
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,15983,38,0.70 [0.30-1.60],0.3914578852533696
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,15954,38,1.03 [0.72-1.48],0.8673831731758932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18244,49,0.92 [0.37-2.28],0.8576428628453474
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,15983,38,0.86 [0.24-3.04],0.8097484981745804
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18471,49,0.84 [0.68-1.03],0.0992858190239606
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18411,49,0.93 [0.48-1.78],0.8227788918588167
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18363,50,2.50 [0.83-7.53],0.1041026520886831
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18453,48,1.02 [0.75-1.38],0.9193258427065354
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15499,37,1.45 [0.81-2.60],0.205681225757508
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15707,38,0.80 [0.37-1.72],0.5691007423840735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15505,38,1.88 [0.64-5.55],0.2529319251280669
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15707,38,2.32 [0.64-8.42],0.2002837021947178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18631,49,1.45 [0.93-2.28],0.100771319293225
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15505,38,1.37 [0.47-3.98],0.5656657579164054
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15575,36,1.15 [0.66-1.98],0.6215974344746529
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15707,38,0.92 [0.51-1.66],0.777080635883467
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15460,36,0.82 [0.34-1.97],0.6637931300211708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15460,36,0.83 [0.43-1.62],0.5889470548664899
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,15929,37,0.97 [0.71-1.31],0.8357781403272813
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,15926,38,1.11 [0.73-1.68],0.6386425207612851
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15538,37,0.81 [0.48-1.35],0.4229920318263992
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,15961,38,1.55 [1.02-2.35],0.040340422698746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15431,38,0.90 [0.41-2.02],0.8059378052912238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15499,37,1.05 [0.70-1.56],0.8129791545371619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,15922,38,1.04 [0.46-2.34],0.9308881558260014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18321,48,0.90 [0.67-1.20],0.4697965547690973
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18173,48,1.37 [0.69-2.72],0.3702593326249024
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18411,49,1.04 [0.74-1.45],0.8343711054476157
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18500,49,0.70 [0.40-1.20],0.1893999780129808
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18062,48,1.10 [0.55-2.20],0.7857562032337646
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,15929,37,1.26 [0.71-2.22],0.4329161090171461
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18105,49,1.31 [0.70-2.47],0.4012361752893391
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15631,36,0.77 [0.45-1.33],0.3557888687343686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18261,48,1.12 [0.51-2.43],0.7829768065669728
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18261,48,1.13 [0.69-1.85],0.6258234846402886
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18454,49,1.12 [0.66-1.90],0.6659745638984188
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18631,49,1.02 [0.53-1.96],0.9460901281178914
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18380,48,1.71 [0.74-3.93],0.2079725954143978
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18453,48,1.70 [0.89-3.25],0.1111515285689995
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18411,49,1.02 [0.46-2.26],0.9584694239570396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18105,49,0.81 [0.43-1.53],0.5141282279402952
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18411,49,0.79 [0.34-1.85],0.5859651712899193
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15631,36,0.57 [0.27-1.22],0.147511565255997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18584,48,1.13 [0.52-2.44],0.7610093553522033
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18411,49,1.02 [0.44-2.36],0.9690371990318178
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18411,49,1.11 [0.58-2.13],0.7547870851101998
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18575,49,0.94 [0.37-2.34],0.8898968733826637
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18598,49,0.81 [0.40-1.63],0.546501830229321
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18261,48,0.75 [0.47-1.21],0.2417733912865117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18575,49,0.93 [0.51-1.67],0.7963463675350747
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18261,48,1.47 [0.81-2.65],0.2056812849646009
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18631,49,1.03 [0.38-2.79],0.9511565201837746
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18405,49,0.83 [0.55-1.26],0.3897996759445516
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18631,49,0.89 [0.36-2.20],0.803381256528002
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18471,49,1.16 [0.45-2.99],0.7560951456754892
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18610,50,1.04 [0.42-2.59],0.932427780945238
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18261,48,0.98 [0.63-1.53],0.9448098435739484
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,15991,37,0.71 [0.29-1.73],0.4475274385784034
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,15954,38,1.03 [0.73-1.46],0.86694508953265
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,15991,37,1.11 [0.53-2.29],0.7833273766630107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18087,48,0.92 [0.69-1.23],0.5820901455512297
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15707,38,1.15 [0.48-2.74],0.7515637782717457
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18261,48,0.90 [0.49-1.67],0.7466033932425371
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18411,49,0.40 [0.20-0.77],0.0064512273090868
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,15983,38,0.91 [0.60-1.38],0.6664292835075749
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,15929,37,0.80 [0.62-1.04],0.0933955977643463
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15431,38,1.27 [0.75-2.16],0.3715986594747111
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15505,38,1.10 [0.75-1.62],0.6277243603396132
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15538,37,1.53 [1.02-2.30],0.0405125182165852
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,17994,48,0.87 [0.48-1.58],0.6452215929691929
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15505,38,0.97 [0.67-1.41],0.8852333611427614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15291,36,1.08 [0.58-2.00],0.804787245053738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18087,48,0.54 [0.18-1.69],0.294004419638035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15575,36,1.74 [0.69-4.40],0.2424180327146243
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15575,36,0.66 [0.26-1.66],0.3771578371699627
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15631,36,0.93 [0.69-1.25],0.6444739845806364
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,15983,38,0.94 [0.31-2.88],0.9172969908629506
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15460,36,1.08 [0.55-2.14],0.8158232104792795
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,17994,48,1.09 [0.77-1.53],0.6445561439669933
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18264,48,0.71 [0.39-1.29],0.2600029116735348
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15707,38,0.71 [0.43-1.15],0.1646399644467503
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18017,48,0.81 [0.39-1.70],0.5800895223622984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15460,36,1.54 [1.09-2.17],0.0138588898416172
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15431,38,1.15 [0.78-1.70],0.4875725192111787
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18604,48,0.88 [0.54-1.43],0.6036221957463745
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,15961,38,1.08 [0.50-2.34],0.8463423513488268
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15505,38,1.28 [0.44-3.74],0.6466321977521772
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18105,49,0.84 [0.53-1.32],0.4525078091112833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18405,49,1.21 [0.85-1.73],0.293383916313652
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15505,38,1.45 [0.78-2.72],0.2408183977886989
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15460,36,0.96 [0.48-1.91],0.906497692449874
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15707,38,1.03 [0.71-1.48],0.8852456833419979
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,15991,37,0.76 [0.51-1.13],0.1801690673983736
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18380,48,1.21 [0.75-1.94],0.4376133926043317
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16003,38,0.76 [0.41-1.40],0.3747737143812645
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18411,49,1.16 [0.55-2.44],0.6971170229371619
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18584,48,1.03 [0.68-1.55],0.8938825795848128
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18405,49,1.06 [0.74-1.51],0.7523812626920237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15680,38,1.34 [0.88-2.04],0.1774279083410374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,15929,37,1.08 [0.81-1.45],0.5917494648491277
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15431,38,1.24 [0.80-1.92],0.330017910613654
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15575,36,0.60 [0.37-0.96],0.0339281930876273
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18405,49,0.90 [0.67-1.21],0.5039556719544014
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,15926,38,1.13 [0.79-1.61],0.5153288685168393
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15460,36,1.06 [0.56-2.00],0.8534094961934686
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15505,38,0.95 [0.61-1.49],0.8338158080618141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,15961,38,0.99 [0.62-1.60],0.970194678497452
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18412,50,1.08 [0.76-1.54],0.6652513505888282
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18087,48,0.90 [0.56-1.44],0.6701433971260027
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15460,36,1.33 [0.61-2.90],0.4731987995948168
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18087,48,1.02 [0.74-1.41],0.8813347301428281
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15460,36,0.67 [0.29-1.51],0.329271529579374
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15499,37,1.07 [0.79-1.45],0.6671125672326708
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,15929,37,0.94 [0.67-1.32],0.7158318990255528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15505,38,0.94 [0.43-2.10],0.8885357917274287
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,17988,48,0.95 [0.67-1.35],0.7896423524782931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15575,36,1.04 [0.54-1.98],0.9109689692844932
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTN,Titin,15460,36,1.00 [0.63-1.59],0.9834853644164488
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,15843,37,1.05 [0.29-3.74],0.940321696198046
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15499,37,1.03 [0.34-3.11],0.9529611419231984
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,15991,37,1.02 [0.70-1.48],0.9173925842135872
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15707,38,1.24 [0.90-1.70],0.1864431341987151
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18261,48,1.04 [0.78-1.39],0.8061021356448554
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15747,37,1.21 [0.61-2.40],0.5916077521109326
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18453,48,1.05 [0.41-2.65],0.9214050933326025
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18575,49,1.04 [0.72-1.50],0.8539859482484689
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,15954,38,0.89 [0.48-1.64],0.7023050593080948
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15472,37,0.99 [0.72-1.35],0.9403988257216596
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18411,49,1.18 [0.69-2.02],0.5478934269380815
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18299,50,0.97 [0.66-1.42],0.8760630947645547
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18412,50,0.85 [0.35-2.05],0.7156833645966897
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15505,38,2.26 [1.31-3.88],0.0031733481480138
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18321,48,1.70 [0.80-3.62],0.1660533342027549
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,15926,38,1.35 [0.51-3.57],0.5487786096878711
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,15983,38,1.18 [0.71-1.95],0.5182380241746382
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15505,38,1.14 [0.70-1.86],0.5899410916341417
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15460,36,1.26 [0.81-1.96],0.3133730394759327
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15631,36,1.06 [0.66-1.69],0.8202110089534269
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,15929,37,1.02 [0.81-1.28],0.86636154850924
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15460,36,1.19 [0.93-1.52],0.1582572998777035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15460,36,0.89 [0.33-2.42],0.8147566520266121
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18261,48,1.06 [0.54-2.06],0.8682691571857044
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18577,50,1.03 [0.64-1.65],0.9172662825734864
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15505,38,2.70 [1.11-6.57],0.0281537354372378
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15431,38,0.76 [0.42-1.41],0.3890118220275407
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,15926,38,0.88 [0.36-2.19],0.7876192021563141
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,15983,38,1.26 [0.91-1.73],0.1680059627956944
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15499,37,1.06 [0.56-2.01],0.8490981257569229
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15669,38,0.61 [0.26-1.43],0.2583362467112412
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15631,36,0.83 [0.51-1.34],0.4417751172620165
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15575,36,1.00 [0.61-1.63],0.9886609286690856
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18321,48,1.01 [0.76-1.35],0.933820108004672
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,15926,38,0.94 [0.61-1.45],0.7712279352490384
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,15954,38,1.37 [0.67-2.79],0.3826808363454704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15460,36,0.78 [0.50-1.21],0.2604838146378275
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18087,48,1.09 [0.83-1.43],0.5160951481143052
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,17994,48,0.47 [0.27-0.80],0.0058352078597704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18087,48,0.68 [0.37-1.26],0.2218010328332901
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15505,38,0.97 [0.67-1.39],0.8617106902619969
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18405,49,0.98 [0.72-1.34],0.9187866340470832
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18143,49,1.06 [0.41-2.70],0.904606514512784
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16003,38,0.99 [0.65-1.53],0.9725396001238186
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18321,48,0.89 [0.24-3.34],0.8626016670827272
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15499,37,1.01 [0.73-1.39],0.9647838514520908
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18478,49,0.96 [0.37-2.49],0.9374677256136325
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18575,49,0.96 [0.41-2.25],0.9249540878219008
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15431,38,1.15 [0.84-1.56],0.3774914650684583
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18576,49,0.74 [0.46-1.20],0.219419358620734
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15505,38,0.64 [0.22-1.89],0.4208936436695821
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18453,48,0.84 [0.53-1.32],0.4491496274187335
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18604,49,0.96 [0.50-1.83],0.8990072405330088
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,15961,38,2.98 [1.28-6.96],0.0115044536874454
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18087,48,1.09 [0.86-1.38],0.4589951943094117
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15538,37,1.78 [0.61-5.20],0.2908121798664078
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,15983,38,0.62 [0.28-1.38],0.2426788297425237
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18321,48,0.95 [0.66-1.37],0.7849194899117972
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16003,38,1.01 [0.66-1.54],0.9742792761482216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18321,48,0.98 [0.57-1.70],0.9560327464714544
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15707,38,1.07 [0.67-1.71],0.7768024834769064
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18321,48,0.97 [0.70-1.33],0.8330482383062945
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,15926,38,0.99 [0.71-1.37],0.9381360442725
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18321,48,0.98 [0.71-1.37],0.9250533103112816
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,15926,38,1.17 [0.50-2.74],0.7113189748651848
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15460,36,0.80 [0.29-2.16],0.6563176645517285
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,15926,38,1.01 [0.62-1.65],0.9772130492382572
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18389,49,1.22 [0.67-2.21],0.5152498896361
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18383,50,0.92 [0.61-1.40],0.7038294027169504
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,15954,38,1.12 [0.50-2.49],0.7876038904535931
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18017,48,0.62 [0.36-1.06],0.0791126662527971
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15707,38,1.22 [0.64-2.32],0.5377762329775249
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18087,48,1.03 [0.67-1.59],0.8797107141719107
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18575,49,0.81 [0.56-1.16],0.2478661193591576
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,17994,48,1.29 [0.56-2.95],0.546546465663704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15631,36,0.65 [0.35-1.22],0.1831426552821355
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18561,48,0.72 [0.39-1.32],0.28363571366528
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15431,38,1.04 [0.71-1.52],0.8360411638732399
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18199,48,0.79 [0.42-1.51],0.4845538798362536
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,15961,38,0.75 [0.33-1.70],0.4876214630890402
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18641,50,0.95 [0.68-1.33],0.7507679982423837
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18411,49,1.17 [0.60-2.27],0.6475782832012065
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18105,49,0.82 [0.55-1.24],0.3547374728333087
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18087,48,1.18 [0.91-1.54],0.2094176941274373
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18017,48,1.06 [0.78-1.44],0.7131487827052396
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,15954,38,1.05 [0.70-1.58],0.8045082932092988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15505,38,1.13 [0.70-1.82],0.6253865594226833
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,15926,38,1.32 [0.63-2.80],0.4628685278128425
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15591,38,0.86 [0.45-1.65],0.6553933147257212
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18549,48,1.21 [0.81-1.80],0.3475042952895201
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17475,41,1.75 [0.97-3.15],0.063975952401777
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18194,48,0.86 [0.46-1.61],0.6321061670478729
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18411,49,0.90 [0.42-1.93],0.787577515914825
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18584,48,0.72 [0.34-1.54],0.3971681551044997
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18105,49,2.00 [0.99-4.06],0.0532823446648939
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18261,48,0.96 [0.59-1.56],0.8589072137947182
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18584,48,1.15 [0.74-1.78],0.5468361747119483
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18553,50,1.28 [0.61-2.71],0.5114331829238683
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15505,38,1.03 [0.60-1.78],0.9015248477798552
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18453,48,1.05 [0.83-1.34],0.6621113758016801
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18017,48,0.92 [0.46-1.85],0.8168609070379977
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,15954,38,1.11 [0.37-3.38],0.8479298319391866
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",15929,37,1.00 [0.81-1.25],0.9701329269443448
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18321,48,0.97 [0.77-1.21],0.7583607495836988
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,15926,38,0.83 [0.31-2.23],0.7063631803116055
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15460,36,1.38 [0.83-2.29],0.2122625156370097
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18105,49,1.09 [0.81-1.47],0.580340482906035
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15631,36,0.87 [0.56-1.37],0.5481073131729118
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15505,38,1.42 [0.49-4.07],0.5174263119869372
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15505,38,1.51 [0.83-2.73],0.1769140522984738
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,17994,48,0.94 [0.66-1.36],0.750165895899614
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18087,48,1.43 [0.89-2.30],0.1355154458245216
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15460,36,1.35 [0.91-2.00],0.1344487607373895
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,15929,37,0.90 [0.63-1.29],0.5766345537405735
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,15954,38,1.51 [0.84-2.71],0.1696378929658322
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15505,38,0.83 [0.31-2.18],0.7025888561066491
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15707,38,1.12 [0.70-1.79],0.6269917934486395
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,15926,38,1.30 [0.96-1.77],0.0928996698450419
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,15929,37,0.98 [0.62-1.56],0.9342515970504072
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,15926,38,1.21 [0.71-2.06],0.4787244597264704
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15538,37,0.92 [0.82-1.03],0.1299087429582812
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15431,38,1.22 [0.54-2.79],0.6297910411267442
Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15499,37,1.04 [0.76-1.42],0.8006358300599103
